
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBABDE92653B633DABDE001F6460EF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontgene">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Genetics">
<meta name="citation_title" content="Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience">
<meta name="citation_author" content="Nerina C Van der Merwe">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Herkulaas MvE Combrink">
<meta name="citation_author_institution" content="Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Kholiwe S Ntaita">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Jaco Oosthuizen">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_publication_date" content="2022 Apr 8">
<meta name="citation_volume" content="13">
<meta name="citation_firstpage" content="834265">
<meta name="citation_doi" content="10.3389/fgene.2022.834265">
<meta name="citation_pmid" content="35464868">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/pdf/fgene-13-834265.pdf">
<meta name="description" content="Breast cancer is a multifaceted disease that currently represents a leading cause of death in women worldwide. Over the past two decades (1998–2020), the National Health Laboratory Service’s Human Genetics Laboratory in central South Africa screened ...">
<meta name="og:title" content="Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Breast cancer is a multifaceted disease that currently represents a leading cause of death in women worldwide. Over the past two decades (1998–2020), the National Health Laboratory Service’s Human Genetics Laboratory in central South Africa screened ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9024354">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fgene.2022.834265"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fgene-13-834265.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9024354%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9024354/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9024354/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontgene.gif" alt="Frontiers in Genetics logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Genetics" title="Link to Frontiers in Genetics" shape="default" href="http://www.frontiersin.org/genetics" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Genet</button></div>. 2022 Apr 8;13:834265. doi: <a href="https://doi.org/10.3389/fgene.2022.834265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fgene.2022.834265</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Genet%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Genet%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Genet%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Genet%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Prevalence of Clinically Relevant Germline <em>BRCA</em> Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20der%20Merwe%20NC%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nerina C Van der Merwe</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nerina C Van der Merwe</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20der%20Merwe%20NC%22%5BAuthor%5D" class="usa-link"><span class="name western">Nerina C Van der Merwe</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Combrink%20HM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Herkulaas MvE Combrink</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Herkulaas MvE Combrink</span></h3>
<div class="p">
<sup>3</sup>
Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">
<sup>4</sup>
Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Combrink%20HM%22%5BAuthor%5D" class="usa-link"><span class="name western">Herkulaas MvE Combrink</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ntaita%20KS%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Kholiwe S Ntaita</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Kholiwe S Ntaita</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ntaita%20KS%22%5BAuthor%5D" class="usa-link"><span class="name western">Kholiwe S Ntaita</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oosthuizen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jaco Oosthuizen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jaco Oosthuizen</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oosthuizen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jaco Oosthuizen</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Bloemfontein, South Africa
</div>
<div id="aff2">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div id="aff3">
<sup>3</sup>
Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div id="aff4">
<sup>4</sup>
Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>
<strong>Edited by:</strong>
<a href="https://loop.frontiersin.org/people/1235486/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Dawn Stephens</a>, Technology Innovation Agency (TIA), South Africa</p></div>
<div class="fn" id="fn2">
<p>
<strong>Reviewed by:</strong>
<a href="https://loop.frontiersin.org/people/1314966/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Rong Bu</a>, King Faisal Specialist Hospital &amp; Research Centre, Saudi Arabia</p>
<p>
<a href="https://loop.frontiersin.org/people/1196152/overview" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Peter Hulick</a>, NorthShore University HealthSystem, United States</p>
</div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Nerina C. Van der Merwe, <span>vanderMerweNC@ufs.ac.za</span>
</p>
</div>
<div class="fn" id="fn3"><p>This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Dec 13; Accepted 2022 Feb 23; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 Van der Merwe, Combrink, Ntaita and Oosthuizen.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9024354  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35464868/" class="usa-link">35464868</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Breast cancer is a multifaceted disease that currently represents a leading cause of death in women worldwide. Over the past two decades (1998–2020), the National Health Laboratory Service’s Human Genetics Laboratory in central South Africa screened more than 2,974 breast and/or ovarian cancer patients for abnormalities characteristic of the widely known familial breast cancer genes, Breast Cancer gene 1 (<em>BRCA1</em>) and Breast Cancer gene 2 (<em>BRCA2</em>)<em>.</em> Patients were stratified according to the presence of family history, age at onset, stage of the disease, ethnicity and mutation status relative to <em>BRCA1/2</em>. Collectively, 481 actionable (likely-to pathogenic) variants were detected in this cohort among the different ethnic/racial groups. A combination of old (pre-2014) and new (post-2014) laboratory techniques was used to identify these variants. Additionally, targeted genotyping was performed as translational research revealed the first three recurrent South African pathogenic variants, namely <em>BRCA1</em> c.1374del (legacy name 1493delC), <em>BRCA1</em> c.2641G&gt;T (legacy name E881X) and <em>BRCA2</em> c.7934del (legacy name 8162delG). This initial flagship study resulted in a cost-effective diagnostic test that enabled screening of a particular ethnic group for these variants. Since then, various non-Afrikaner frequent variants were identified that were proven to represent recurrent variants. These include <em>BRCA2</em> c.5771_5774del (legacy name 5999del4) and <em>BRCA2</em> c.582G&gt;A, both Black African founder mutations. By performing innovative translational research, medical science in South Africa can adopt first-world technologies into its healthcare context as a developing country. Over the past two decades, the progress made in the public sector enabled a pivotal shift away from population-directed genetic testing to the screening of potentially all breast and ovarian cancer patients, irrespective of ethnicity, family history or immunohistochemical status. The modifications over the years complied with international standards and guidelines aimed at universal healthcare for all. This article shares all the cohort stratifications and the likely-to pathogenic variants detected.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> familial breast and ovarian cancer, predisposing genes <em>BRCA1/2</em>
, central South Africa, National Health Laboratory Service, public sector</p></section></section><section id="s1"><h2 class="pmc_sec_title">1 Introduction</h2>
<p>The two familial breast cancer (BC) genes, Breast Cancer gene 1 (<em>BRCA1</em>) and Breast Cancer gene 2 (<em>BRCA2</em>), are highly penetrant and contribute to various cellular events ranging from the response to DNA damage to control of the cell cycle and apoptosis (<a href="#B90" class="usa-link" aria-describedby="B90">Yoshida and Miki, 2004</a>). Germline pathogenic variants in these genes create genetic instability impacting their capacity to repair the damage. Likely- to pathogenic variants in these genes are associated with hypersensitivity in BC patients. Their presence results in potentially severe radiotherapy complications during treatment due to spontaneous and enhanced radio-sensitivity (<a href="#B18" class="usa-link" aria-describedby="B18">Chistiakov et al., 2008</a>; <a href="#B40" class="usa-link" aria-describedby="B40">Kan and Zhang, 2015</a>). Disruptive <em>BRCA1/2</em> variants are associated with a predisposition to breast and ovarian cancer, and although at a lower frequency, prostate, pancreas and other cancer types are also linked to pathogenic <em>BRCA1/2</em> variants. Although these two high-impact cancer-predisposing genes were discovered more than two decades ago, they have dominated the field of BC genetics ever since.</p>
<p>BC is the most common cancer and the leading cause of cancer-related death in females worldwide (<a href="#B15" class="usa-link" aria-describedby="B15">Bray et al., 2018</a>). Most cases are sporadic. However, 5%–10% can be attributed to a hereditary component (<a href="#B45" class="usa-link" aria-describedby="B45">Larsen et al., 2014</a>). The disease was mostly considered an illness of the affluent; however, the incidence in developing countries, such as South Africa (SA), is rapidly increasing (<a href="#B38" class="usa-link" aria-describedby="B38">Joffe et al., 2018</a>). The age-standardized annual BC incidence rate (ASR) per 100,000 ranges between 52.92 and 79.3 for Asian, Caucasian and mixed-race SA women, compared to 29.1 for Black women. The average ASR, however, is currently 1 in 32 for a SA female to develop the disease (<a href="#B28" class="usa-link" aria-describedby="B28">Francies et al., 2015</a>).</p>
<p>The complex history of sub-Saharan Africa has highlighted the diverse populations of SA regarding the field of medical and population genetics (<a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>). Although SA harbors over 60 million people, each of its main population groups has a unique origin. This diversity resulted from various migration events from all over the globe, such as European colonialism from predominantly north-western Europe, which gave rise to the Afrikaner with its Anglo-European descent (<a href="#B7" class="usa-link" aria-describedby="B7">Attlee, 1947</a>). Simultaneously, the indigenous expansion of Black Africans to the southern tip of the African continent resulted in approximately 80% of the entire SA population being neither culturally, linguistically, nor genetically homogenous (<a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>).</p>
<p>Additional genetic lineages were introduced by laborers arriving from south Asia. Their arrival resulted in admixture between various groups already residing in SA, including the indigenous African people such as the Khoikhoi, the San, and the African Xhosa tribe (<a href="#B7" class="usa-link" aria-describedby="B7">Attlee, 1947</a>). These groups were eventually absorbed into the mixed ancestry group (<a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>). Finally, the last major grouping (Asian population) originated from admixture of individuals from mainland India, neighboring countries such as Bangladesh, and the Mixed Ancestry population of SA (<a href="#B87" class="usa-link" aria-describedby="B87">Vishnu and Morrell, 1991</a>). Therefore, the modern-day Asian (specifically the SA Indian) population comprises mostly of people who migrated from mainland India to SA over 300 years, with admixture involving countries from Eurasia and Africa (<a href="#B52" class="usa-link" aria-describedby="B52">Mesthrie, 2006</a>; <a href="#B37" class="usa-link" aria-describedby="B37">Isaacs et al., 2013</a>). As our genomes reflect a record of historical events, so too does the genetic diversity in the field of hereditary breast and ovarian cancer (HBOC) reflect the complexity of the SA population (<a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al., 2020</a>; <a href="#B21" class="usa-link" aria-describedby="B21">Combrink et al., 2021</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>).</p>
<p>Patients with likely- to pathogenic germline variants in these high-risk genes have an increased predisposition to develop BC and/or ovarian cancer (OVC) throughout their lifetime. According to global statistics, the cumulative risk for <em>BRCA1</em> and <em>BRCA2</em> mutation carriers to develop BC before 80 years of age is 40%–87% and 27%–84%, respectively. The associated risk for OVC varies from 16%–68% and 11%–30%, respectively (<a href="#B42" class="usa-link" aria-describedby="B42">Kuchenbaecker et al., 2017</a>). The etiology related to hereditary BC and OVC in SA derived great benefit from population-based genetic research (<a href="#B66" class="usa-link" aria-describedby="B66">Reeves et al., 2004</a>; <a href="#B3" class="usa-link" aria-describedby="B3">Agenbag, 2005</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Van der Merwe and van Rensburg, 2009</a>; <a href="#B74" class="usa-link" aria-describedby="B74">Sluiter and Van Rensburg, 2011</a>; <a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Peter, 2014</a>; <a href="#B16" class="usa-link" aria-describedby="B16">Chen, 2015</a>; <a href="#B28" class="usa-link" aria-describedby="B28">Francies et al., 2015</a>; <a href="#B20" class="usa-link" aria-describedby="B20">Combrink, 2016</a>; <a href="#B55" class="usa-link" aria-describedby="B55">Moeti, 2016</a>; <a href="#B60" class="usa-link" aria-describedby="B60">Oosthuizen, 2016</a>; <a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al., 2020</a>; <a href="#B21" class="usa-link" aria-describedby="B21">Combrink et al., 2021</a>; <a href="#B48" class="usa-link" aria-describedby="B48">Mampunye et al., 2021</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>), resulting in the identification of five founder variants representative of three of the four major ethnic groups in the country (<em>BRCA1</em> c.1374del [rs397508862], <em>BRCA1</em> c.2641G&gt;T [rs39750888] (<a href="#B66" class="usa-link" aria-describedby="B66">Reeves et al., 2004</a>); <em>BRCA2</em> c.7934del [rs80359688] (<a href="#B84" class="usa-link" aria-describedby="B84">Van der Merwe and van Rensburg, 2009</a>); <em>BRCA2</em> c.5771_5774del [80359535] (<a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>); <em>BRCA2</em> c.582G&gt;A [rs80358810] (<a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>)).</p>
<p>The SA studies performed to date reflect substantial variation in the yield of actionable (likely-pathogenic and pathogenic) germline variants identified in the country. As only 4.5% of the SA total budget is allocated to healthcare expenditure, it burdens an already stressed public sector to seek cost-effective alternatives for routine diagnostic testing of familial breast and ovarian cancer patients. This single-institution public sector study aimed to determine the range and positive mutation percentage of <em>BRCA1</em> and <em>BRCA2</em> actionable variants in an unselected large cohort of BC and OVC patients. These patients were screened using various technologies ranging from targeted genotyping to comprehensive screening, employing both older and new technologies. Our results prompted us to contemplate the most appropriate workflow for SA state-owned pathology laboratories to provide cost-effective genetic assessment in a financially constraint health sector.</p></section><section id="s2"><h2 class="pmc_sec_title">2 Materials and Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">2.1 Study Population</h3>
<p>A total of 2,975 BC and/or OVC patients were consulted at the National Health Laboratory Service (NHLS) Human Genetics Laboratory in Bloemfontein between 01/01/1998 and 31/12/2020, of whom 81 patients had incomplete data and were excluded from the analysis. The remaining 2,894 BC and/or OVC patients (2,733 females and 161 males) were examined by targeted genotyping or comprehensive screening of <em>BRCA1/2</em> (<a href="#F1" class="usa-link">Figure 1</a>). These BC and/or OVC patients attended their closest genetic clinic at a regional or provincial hospital, where they were referred for diagnostic genetic testing through their local genetic counselor or attending physician. Indications for testing included BC diagnosed at age 45 years or less or a significant family history (at least one first-degree family member with premenopausal BC or OVC, or multiple second-degree family members with premenopausal BC and/or OVC, or males with BC at any age).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9024354_fgene-13-834265-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c32/9024354/4ff9fc727468/fgene-13-834265-g001.jpg" loading="lazy" height="528" width="708" alt="FIGURE 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Individuals screened at the NHLS Human Genetics laboratory in Bloemfontein between 1998 and 2020, using a combination of investigative methods ranging from targeted genotyping to comprehensive screening. The numbers screened together with the success rates are indicated. Pos, positives; neg, negatives; HRMA, high resolution melting analysis; NGS, next-generation sequencing; MLPA, multiplex ligation-dependent probe amplification.</p></figcaption></figure><p>Ethnicity was determined by patients’ self-identification at the time of consultation. The major ethnic group classifications have sub-classifications, some contextualized specifically to the SA demographic profile (<a href="#T1" class="usa-link">Table 1</a>). The majority (<em>n</em> = 975) was Caucasian, followed by the Black African (<em>n</em> = 753) and mixed ancestry groups (<em>n</em> = 669), with the Asian group being the minority (<em>n</em> = 297). The ethnicities for the remainder of patients (<em>n</em> = 200) were either not indicated or unknown. The distribution of the patients across the various ethnic groups reflected the demographic profile of the breast clinic only and did not reflect BC incidence within each of these groups. Additionally, patient reports generated over the years were retrospectively analyzed to collect information on epidemiological characteristics, which specifically focused on 1) presence of a family history of BC and/or OVC; 2) age at onset; 3) stage of the disease; 4) ethnicity; and 5) mutation status.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Self-identified ethnicity of consecutive BC and/or OVC patients included in the study (<em>n</em> = 2,896).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Major ethnic classification</th>
<th align="center" rowspan="1" colspan="1">Sub-ethnic classification</th>
<th align="center" rowspan="1" colspan="1">Count</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">South African Indian, Malay, Pakistani, Chinese, Japanese, Bengali, Mongolian</td>
<td align="center" rowspan="1" colspan="1">297</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Black African</td>
<td align="left" rowspan="1" colspan="1">All Black African nationalities</td>
<td valign="top" align="center" rowspan="1" colspan="1">753</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">South African Afrikaner, British, and European descent</td>
<td valign="top" align="center" rowspan="1" colspan="1">975</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mixed ancestry</td>
<td align="left" rowspan="1" colspan="1">A South African subgroup of people that comprise a mixture of any of the abovementioned ethnic classifications</td>
<td valign="top" align="center" rowspan="1" colspan="1">669</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unknown</td>
<td align="left" rowspan="1" colspan="1">Not specified</td>
<td valign="top" align="center" rowspan="1" colspan="1">200</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Majority of individuals included in this cohort were diagnosed with BC and/or OVC. All the individuals had received pre- and post-test counseling at their respective referral centers. Information regarding personal and family history, as well as written informed consent for DNA testing, were obtained. The cohort included patients with a positive family history (two or more affected family members) for BC and/or OVC, with most representing low-risk patients who had no prior knowledge of a family history of either condition but were diagnosed at an early age of onset (&lt;40 years). The Health Sciences Research Ethics Committee (HSREC) of the University of the Free State in Bloemfontein, SA, approved all study protocols submitted since 1995 (ETOVS 31/95; ECUFS 31B/95; ECUFS 31C/95; ETOVS 49/06; ETOVS 65/08; ECUFS 107/2014; ECUFS 108/2014; UFS-HSD2019/1835/2910 and UFS-HSD2020/0194/3006). The NHLS permitted the use of the data (reference PR2110611).</p></section><section id="s2-2"><h3 class="pmc_sec_title">2.2 Laboratory Methods</h3>
<p>DNA was extracted from peripheral blood using a standard extraction method. The concentration and purity were determined using spectrophotometry. Targeted genotyping for the founder and recurrent actionable variants was performed using the LightCycler<sup>®</sup> 480 Genotyping Master Mix (Roche Diagnostics, Germany) on the LightCycler<sup>®</sup> 480 II real-time instrument (Roche Diagnostics, Germany). These assays employ hybridization and simple probe technology described by Oosthuizen (<a href="#B60" class="usa-link" aria-describedby="B60">Oosthuizen, 2016</a>). Targeted genotyping was performed using a standard real-time PCR regime, followed by melt curve analysis. Conventional mutation screening for single nucleotide variants (SNVs) and smaller indels was initially performed for a subset of patients described previously (<a href="#B20" class="usa-link" aria-describedby="B20">Combrink, 2016</a>; <a href="#B60" class="usa-link" aria-describedby="B60">Oosthuizen, 2016</a>). This approach involved a combination of older technology-based techniques including High-Resolution Melt Analysis (HRMA), the protein truncation test (PTT) and Sanger sequencing (<a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al., 2020</a>). A total of 340 patients were screened using a combination of these older techniques (<a href="#F1" class="usa-link">Figure 1</a>).</p>
<p>Individuals screened using the conventional approach were subjected to copy number variants (CNVs) analysis using Multiplex Ligation-dependent Probe Amplification (MLPA). The assays used included the SALSA<sup>®</sup> MLPA<sup>®</sup> P002-C1 and SALSA<sup>®</sup> MLPA<sup>®</sup> P002-D1 for <em>BRCA1</em>, with SALSA<sup>®</sup> MLPA<sup>®</sup> P045-B3 used for <em>BRCA2</em> (MRC-Holland, Amsterdam, Netherlands). The products were run together with a size standard on an ABI 3130XL Genetic analyzer (Applied Biosystems, Carlsbad, CA, United States). MLPA-positive results, especially in the case of single exon deletions, were corroborated using an alternative confirmation assay for each of the genes, namely SALSA<sup>®</sup> MLPA<sup>®</sup> P087-C1 for <em>BRCA1</em> and SALSA<sup>®</sup> MLPA<sup>®</sup> P077-A3 for <em>BRCA2</em>. All the data were analyzed using GeneMarker<sup>®</sup> software version 2.6.4 (SoftGenetics, LLC, State College, PA, United States). The CNVs were named according to the Human Genome Variation Society (<a href="http://www.hgvs.org/varnomen" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.HGVS.org/varnomen</a>) guidelines and classified using the adapted recommendations of the American Society of Medical Genetics and Genomics (ACMG) for the interpretation and reporting of single-gene CNVs (<a href="#B14" class="usa-link" aria-describedby="B14">Brandt et al., 2020</a>).</p>
<p>Once introduced, next-generation sequencing (NGS) was performed to screen the remainder of samples (<em>n</em> = 1,089), using the Oncomine™ BRCA Research Assay (Life Technologies, Carlsbad, CA, United States). The primer pools targeted both genes’ entire coding region and splice-site junctions. Multiplexed primer pools were used to construct the amplicon library using PCR-based targeted amplification. Sequencing was performed on the Ion Proton and S5 Platforms (Life Technologies, Carlsbad, CA, United States), and the Ion Reporter™ Software was used to filter out artifacts and annotate the variants. Raw signal data were analyzed as described by <a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al. (2020)</a>. The average read-depths obtained were 581×, ranging between 148 and 1,965×. Using the depth per read, quartile statistics were applied to calculate average depth distribution around the mean across the NGS samples. Samples that were located within the 2nd and 3rd quartiles were selected to construct a CNV baseline with the Ion Reporter CNV VCIB 4.0.0.1 algorithm. CNV detection was performed using an algorithm that normalized depth coverage across amplicons to predict the copy number or ploidy states. The computed baseline included a minimum of 100 control samples (each with an average of 24 million bases called and a read count of 215,000), using regions with known ploidy states (<a href="https://assets.thermofisher.com/TFS-Assets/LSG/brochures/CNV-Detection-by-Ion.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.thermofisher.com/TFS-Assets/LSG/brochures/CNV-Detection-by-Ion.pdf</a>). MLPA was performed to confirm all CNVs detected using NGS. Novel or complex sequence variants were confirmed by means of Sanger DNA sequencing (ABI Prism BigDye<sup>®</sup> Terminator v3.1 cycle sequencing kit, Foster City, CA, United States), using an Applied Biosystems 3130 automated sequencer (Life Technologies, Foster City, CA, United States).</p>
<p>The clinical significance of variants was determined based on the American College of Medical Genetics guidelines (ACMG, classification confirmed on 02/12/2021) (<a href="#B69" class="usa-link" aria-describedby="B69">Richards et al., 2015</a>) and evaluated from freely accessible public databases such as ClinVar and the genomic search engine VarSome (<a href="#B41" class="usa-link" aria-describedby="B41">Kopanos et al., 2019</a>). The variant nomenclature was used according to Human Genome Variation Society (HGVS) recommendations (<a href="http://www.hgvs.org/rec.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hgvs.org/rec.html</a>). <em>BRCA1/2</em> variants were numbered and annotated using the National Center for Biotechnology Information (NCBI) chromosomes and transcript reference sequences (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000013.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000013.11</a>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a>), respectively. To prevent potential biases between the different laboratory techniques utilized for mutation screening throughout the years, all potential nucleotide changes were confirmed using Sanger sequencing. The analyses were confirmed using the same mutation detection databases and reference sequences.</p></section></section><section id="s3"><h2 class="pmc_sec_title">3 Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">3.1 Composition of Cohort</h3>
<p>The influence of various SA founder variants is reflected in the relatively high mutation-positive rates observed for targeted genotyping (<a href="#F1" class="usa-link">Figure 1</a>), with 16.8% observed using population-directed targeted genotyping (<em>n</em> = 453). Although the initial screening was based on the individual’s ethnicity, the positive mutation rate decreased when cases were screened using a broader approach that included all of the commonly occurring SA variants (11.9%, <em>n</em> = 694). Of the 1,429 patients comprehensively screened, 137 (9.2%) carried a likely- to pathogenic <em>BRCA1/2</em> variant. Although the majority represented SNV changes consisting predominantly of substitutions and deletions, eight CNVs were identified. Regarding the SA mutation spectrum, the Afrikaner founder variant <em>BRCA2</em> c.7934del (rs80359688) was the most common, followed by the Black African founder variant <em>BRCA2</em> c.5771_5774del (rs80359535).</p>
<p>An inherited susceptibility was confirmed in 51.5% of affected family members tested (<em>n</em> = 66), that carried the actionable variant segregating in the family (<a href="#F1" class="usa-link">Figure 1</a>). A relatively low number of unaffected family members (<em>n</em> = 252) were genotyped for various family-specific variants. The positive mutation rate for this group was high (40.7%). By knowing their mutation status, these patients were included in various cancer screening programs to facilitate earlier detection and a potentially better prognosis in case of a cancer diagnosis.</p></section><section id="s3-2"><h3 class="pmc_sec_title">3.2 Epidemiology</h3>
<p>The epidemiological data were analyzed according to the five variables highlighted, namely a family history of BC and/or OVC, age at onset, stage of the disease, ethnicity and mutation status. Regarding the age at onset, the majority of patients tested fell in the 40–49 age group (collectively 27.7%), followed by the 50–59 age group (21.2%) (<a href="#T2" class="usa-link">Table 2</a>). These two age intervals also delivered the highest percentage mutation-positive results compared to the other age groups, namely 4.5% and 3.8%, respectively. Only three (0.5%) of the patients identified with a <em>BRCA1/2</em> actionable variant in the 20–29 age group were observed. These positive patients represented approximately one-third of patients tested in this age group. These patients either represented high-risk BC/OVC families or were diagnosed with aggressive disease early and were therefore genetically screened (<a href="#T2" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Comparison between the number of mutation-positive versus mutation-negative patients (reflected in percentages) observed per ten-year intervals.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Age group</th>
<th align="center" rowspan="1" colspan="1">Mutation negative (<em>n</em> = 2,413)</th>
<th align="center" rowspan="1" colspan="1">Mutation positive (<em>n</em> = 481)</th>
<th align="center" rowspan="1" colspan="1">Total (%)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">0–19 (<em>n</em> = 3)</td>
<td align="center" rowspan="1" colspan="1">0.10</td>
<td align="center" rowspan="1" colspan="1">0.00</td>
<td align="center" rowspan="1" colspan="1">0.10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">20–29 (<em>n</em> = 62)</td>
<td align="center" rowspan="1" colspan="1">1.66</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.48</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.14</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">30–39 (<em>n</em> = 480)</td>
<td align="center" rowspan="1" colspan="1">13.96</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.63</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.59</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">40–49 (<em>n</em> = 800)</td>
<td align="center" rowspan="1" colspan="1">23.15</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.49</td>
<td valign="top" align="center" rowspan="1" colspan="1">27.64</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">50–59 (<em>n</em> = 616)</td>
<td align="center" rowspan="1" colspan="1">17.45</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.84</td>
<td valign="top" align="center" rowspan="1" colspan="1">21.29</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">60–69 (<em>n</em> = 467)</td>
<td align="center" rowspan="1" colspan="1">13.41</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.73</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.14</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">70–79 (<em>n</em> = 278)</td>
<td align="center" rowspan="1" colspan="1">8.05</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.55</td>
<td valign="top" align="center" rowspan="1" colspan="1">9.61</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">80–89 (<em>n</em> = 108)</td>
<td align="center" rowspan="1" colspan="1">3.25</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.48</td>
<td valign="top" align="center" rowspan="1" colspan="1">3.73</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">90+ (<em>n</em> = 21)</td>
<td align="center" rowspan="1" colspan="1">0.59</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.14</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.73</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unknown (<em>n</em> = 59)</td>
<td align="center" rowspan="1" colspan="1">1.76</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.28</td>
<td valign="top" align="center" rowspan="1" colspan="1">2.04</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total (%)</td>
<td align="center" rowspan="1" colspan="1">83.38</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.62</td>
<td valign="top" align="center" rowspan="1" colspan="1">100.00</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Of the 481 mutation carriers identified, the majority were Caucasian. However, the data for this grouping were skewed due to the translational research performed before 1998, revealing the presence of three common founder variants in the Caucasian sub-category Afrikaner group (<a href="#T1" class="usa-link">Table 1</a>). This research initially involved mostly Afrikaner patients with a positive family history of BC and/or OVC being screened. This group served as the ideal research group due to proven extended high linkage disequilibrium with various founder effects reported. This SA group is considered a fruitful “hunting ground” for pathogenic variants associated with disease (<a href="#B32" class="usa-link" aria-describedby="B32">Hall et al., 2002</a>; <a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>). The presence of these <em>BRCA1/2</em> founder variants increased the mutation positivity rate to a remarkable 8.12%, delivering the highest positivity rate for Caucasians, namely 24.1%. The mutation positivity rate is an indicator used as a proxy for the relative percentage of patients that tested positive out of the total sample population (<a href="#T3" class="usa-link">Table 3</a>).</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Illustration of the mutation detection and positivity rate per major population group (reflected in percentages) observed for the major groups.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Ethnic group</th>
<th align="center" rowspan="1" colspan="1">Mutation positive (<em>n</em> = 481)</th>
<th align="center" rowspan="1" colspan="1">Mutation negative (<em>n</em> = 2,413) (%)</th>
<th align="center" rowspan="1" colspan="1">Mutation positivity rate (%)</th>
<th align="center" rowspan="1" colspan="1">Total (%)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">Asian (<em>n</em> = 297)</td>
<td align="center" rowspan="1" colspan="1">1.62</td>
<td align="center" rowspan="1" colspan="1">8.64</td>
<td align="center" rowspan="1" colspan="1">15.8</td>
<td align="center" rowspan="1" colspan="1">10.26</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Black African (<em>n</em> = 753)</td>
<td align="center" rowspan="1" colspan="1">3.77</td>
<td valign="top" align="center" rowspan="1" colspan="1">22.25</td>
<td valign="top" align="center" rowspan="1" colspan="1">14.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">26.02</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Caucasian (<em>n</em> = 975)</td>
<td align="center" rowspan="1" colspan="1">8.12</td>
<td valign="top" align="center" rowspan="1" colspan="1">25.57</td>
<td valign="top" align="center" rowspan="1" colspan="1">24.1</td>
<td valign="top" align="center" rowspan="1" colspan="1">33.69</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mixed ancestry (<em>n</em> = 669)</td>
<td align="center" rowspan="1" colspan="1">2.70</td>
<td valign="top" align="center" rowspan="1" colspan="1">20.42</td>
<td valign="top" align="center" rowspan="1" colspan="1">11.7</td>
<td valign="top" align="center" rowspan="1" colspan="1">23.12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unknown (<em>n</em> = 200)</td>
<td align="center" rowspan="1" colspan="1">0.41</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.50</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.0</td>
<td valign="top" align="center" rowspan="1" colspan="1">6.91</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total (%)</td>
<td align="center" rowspan="1" colspan="1">16.62</td>
<td valign="top" align="center" rowspan="1" colspan="1">83.38</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">100.00</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Information regarding the presence or absence of a family history of BC and/or OVC was available for most patients (<a href="#s12" class="usa-link">Supplementary Table S1</a>), with 5.8% designated as unknown (<em>n</em> = 141). Patients adopted as children contributed to the unknown category, as they had no prior family information. More than 80% of patients (<em>n</em> = 392) carrying an actionable <em>BRCA1/2</em> variant reported family members affected with BC and other cancer types. Although the information regarding family structure varied from being limited (lacking maternal or paternal lineages and ages at diagnoses) to extensive (three-generation pedigrees with both paternal and maternal lineages indicated), the percentage highlights the consistent importance of determining the family history as an effective selection criterion for <em>BRCA1/2</em> genetic testing. Despite reporting a positive family history of BC and/OVC, no actionable variants were detected for 59.9% (<em>n</em> = 1,445) of patients screened (<a href="#s12" class="usa-link">Supplementary Table S1</a>).</p>
<p>As the African continent has previously been associated with more aggressive breast disease and higher mortality rates due to late-stage presentation, the stage at diagnosis was compared between the ethnicities for 455 patients for whom the relevant information was available (<a href="#s12" class="usa-link">Supplementary Table S2</a>). The stage of disease at diagnosis for two groups (the Caucasians and individuals of mixed ancestry) was similar, with most patients diagnosed with Stage 2 disease. These two groups had the highest percentage of Stage 1 BC (10.6%), indicating increased community awareness and successful BC screening programs in the public health sector. These groups also exhibited a low number of patients diagnosed with Stage 4 disease (8.5% and 6.1%, respectively; <a href="#s12" class="usa-link">Supplementary Table S2</a>). This pattern was similar to that for the Black African group, except Stage 3 disease being the most prevalent. This finding still hints towards a later stage at presentation. However, it has improved significantly as a mere 7.6% of patients had Stage 4 disease at diagnosis. The Asian population of SA was the most alarming of the four ethnic groups due to the high percentage of patients diagnosed with Stage 4 disease (16.2%). However, this percentage could have been skewed due to the small sample size of this particular group (<em>n</em> = 37).</p>
<p>Patients affected with BC and/or OVC were divided according to unilateral and bilateral disease related to the presence or absence of a <em>BRCA1/2</em> variant (<a href="#s12" class="usa-link">Supplementary Table S3</a>). The majority of patients presented with unilateral BC, with only 220 cases affected with bilateral disease and a further 91 affected with OVC. A small number of patients (<em>n</em> = 62) were also diagnosed with a secondary cancer type not specified here (<a href="#s12" class="usa-link">Supplementary Table S3</a>). The mutation-positive rates in this cohort varied between the two BC groups, with each group exhibiting similar success rates. For the OVC cases, the detection rate was considerably higher (21.9%), as 20 patients in total carried <em>BRCA1/2</em> actionable variants (9 in <em>BRCA1</em> and 11 in <em>BRCA2</em>).</p></section><section id="s3-3"><h3 class="pmc_sec_title">3.3 Mutation Spectrum</h3>
<p>Apart from targeted genotyping, mutation screening of 1,429 patients revealed a wide range of variants across the SA population groups. The data were generated from 340 patients screened using older mutation screening techniques, with a further 1,089 assessed by NGS. The data of the two sets were incorporated and are presented in <a href="#T4" class="usa-link">Table 4</a>. A total of 132 (9.2%) patients representing 73 likely- to pathogenic variants were identified (<em>n</em> = 117 for NGS and <em>n</em> = 15 using older technologies), with 57.6% (76/132) representing <em>BRCA2</em>. Twenty-two of these actionable variants were classified as splice-site variants, mainly located in the intronic splice site boundaries. Various CNVs were detected, ranging from single exon to complete gene deletions. These CNVs have been previously described by <a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al. (2020)</a>. Across the genes, NGS detected 344 variants, with only 14% present in a homozygous state. Unique variation in the SA population resulted in 196 variants identified with a minor allele frequency (MAF) below 0.01, with 47 consequently being classified as variants of unknown clinical significance (VUS), predominantly in <em>BRCA2</em>. Of these 47 variants, 30 were completely novel and not detected in international databases used for variant interpretation (<a href="#T4" class="usa-link">Table 4</a>).</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Summary of variants detected during comprehensive screening of 1,429 patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Variant category</th>
<th align="center" rowspan="1" colspan="1">Patients (<em>n</em>)</th>
<th align="center" rowspan="1" colspan="1">Variants (<em>n</em>)</th>
<th align="center" rowspan="1" colspan="1">Homozygous variants (<em>n</em>)</th>
<th align="center" rowspan="1" colspan="1">Heterozygous variants (<em>n</em>)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> actionable variants</td>
<td align="center" rowspan="1" colspan="1">55</td>
<td align="center" rowspan="1" colspan="1">34</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">34</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em> actionable variants</td>
<td align="center" rowspan="1" colspan="1">76</td>
<td align="center" rowspan="1" colspan="1">39</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">39</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total # of <em>BRCA1</em> variants</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">146</td>
<td align="center" rowspan="1" colspan="1">22</td>
<td align="center" rowspan="1" colspan="1">124</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total # of <em>BRCA2</em> variants</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">198</td>
<td align="center" rowspan="1" colspan="1">26</td>
<td align="center" rowspan="1" colspan="1">172</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total # of VUSes in <em>BRCA1</em>
</td>
<td align="center" rowspan="1" colspan="1">30</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total # of VUSes in <em>BRCA2</em>
</td>
<td align="center" rowspan="1" colspan="1">96</td>
<td align="center" rowspan="1" colspan="1">30</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> variants with MAF &lt;0.01</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">84</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">83</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em> variants with MAF &lt;0.01</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">112</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">112</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Splice-site variants in <em>BRCA1</em>
</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Splice-site variants in <em>BRCA2</em>
</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Novel variants in <em>BRCA1</em>
</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">13</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Novel variants in <em>BRCA2</em>
</td>
<td align="center" rowspan="1" colspan="1">na</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Copy number variants in <em>BRCA1</em>
</td>
<td align="center" rowspan="1" colspan="1">13</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Copy number variants in <em>BRCA2</em>
</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>VUS, variant of unknown clinical significance; na, not applicable.</p></div></div></section><p>The mutation positivity rates for the main SA ethnicities varied, with 9.2% reported for the Black African group (44/479), 6.6% for the Asians (12/180), 18.1% for the Caucasians (25/138), 13.2% for the mixed ancestry group (22/167), with 11.8% allocated to the group of unknown ethnicity (14/118). From the 59 actionable variants detected across the populations using NGS, 23 were detected in the Black African group, 10 in the Asian group, 12 in the Caucasian group, 13 in the mixed ancestry group, with 12 falling into the group of unknown ethnicity. Only seven of the 59 variants were detected in two separate populations, with a single pathogenic variant (<em>BRCA2</em> c.582G&gt;A [rs80358810]) observed across all four main ethnic groups. However, the remainder of the actionable variants (51/59) were restricted to a single population group. Recurrence of these likely- to pathogenic variants was low in the NGS cohort with 66.1% (39/59) observed for a single patient. Another 18.6% of the variants (11/59) were detected twice, followed by 6.8% (4/59) identified in three patients each. A small percentage (8.5%) was common and represented the three most common founder variants, namely <em>BRCA2</em> c.5771_5774del (detected in eight patients), <em>BRCA2</em> c.582G&gt;A (10 patients) and <em>BRCA2</em> c.7934del (detected 17 times in the NGS cohort alone).</p></section><section id="s3-4"><h3 class="pmc_sec_title">3.4 Genomic Consequence</h3>
<p>When investigating the consequences of the variation observed, it varied for the two genes (<a href="#F2" class="usa-link">Figures 2A,B</a>). The genomic variant frequencies and associated consequences were only based on the NGS data. Although the bulk of variation for <em>BRCA1</em> was represented by non-coding transcript variants primarily present in the intronic regions (<a href="#F2" class="usa-link">Figure 2A</a>), the consequence of these variants has the potential to affect both overlapping genes, namely <em>BRCA1</em> (NM_000294.4 [43,044 295–43,125 364] and <em>Homo sapiens</em> Rho family GTPase 2 (<em>RND2</em>—<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005440.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005440.5</a> [43,025 231–43,032 041]), involving a total of eight overlapping transcripts and five regulatory features. For <em>BRCA2</em>, the variation was present in the form of downstream changes observed in the 3′ untranslated region (<a href="#F2" class="usa-link">Figure 2B</a>). In comparison, the genomic variation observed in this section of chromosome 13 has the potential to affect three overlapping genes, namely <em>BRCA2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a> [32,315 508–32,400 268]), <em>Homo sapiens</em> zygote arrest 1 like (<em>ZAR1L</em>—<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001136571.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001136571.2</a> [32,303 699–32,315 363]) and NEDD4 Binding Protein 2 Like 2 (<em>N4BP2L2</em>—NM_001,387,001.1 [32,432 485–32,538 795]), encompassing 28 overlapping transcripts and four regulatory features.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9024354_fgene-13-834265-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c32/9024354/1dbe6297e0ac/fgene-13-834265-g002.jpg" loading="lazy" height="265" width="708" alt="FIGURE 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Diagrams indicating the genomic variant frequencies for the <em>BRCA1</em> and <em>BRCA2</em> loci amongst 1,089 patients screened using NGS. <strong>(A)</strong> The consequence ratios relative to variant frequencies observed for the <em>BRCA1</em> locus. <strong>(B)</strong> The consequence ratios relative to variant frequencies observed for the <em>BRCA2</em> locus.</p></figcaption></figure><p>On DNA level, only a small percentage of the observed <em>BRCA1</em> changes represented variants potentially having an impact, namely frameshift (9%), splice- (3%), and stop-gained variants (5%) (<a href="#F3" class="usa-link">Figure 3A</a>). Their contribution increased on protein level (<a href="#F3" class="usa-link">Figure 3B</a>), directly impacting the protein and consequently efficient DNA repair, as 23% resulted in a prematurely truncated peptide (15% frameshift and 8% stop-gained variants) together with 5% missense variants. The majority of the actionable variants were detected in <em>BRCA1</em> exon 10. Approximately half of the variants observed at protein level represented missense variants, of which 14/55 changes were classified as VUSes. The missense variants were distributed throughout the gene, with the majority located outside of functional or disordered domains (<a href="#T4" class="usa-link">Table 4</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9024354_fgene-13-834265-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c32/9024354/f06b76cd8bee/fgene-13-834265-g003.jpg" loading="lazy" height="517" width="708" alt="FIGURE 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Diagrams indicating the variants detected for the two familial BC genes on DNA and protein level amongst 1,089 BC and/or OVC patients screened using NGS. <strong>(A)</strong> The consequence ratios (in percentages) predicted for <em>BRCA1</em> on a DNA level. <strong>(B)</strong> The consequence ratios predicted for <em>BRCA1</em> on a protein level. <strong>(C)</strong> The consequence ratios predicted for <em>BRCA2</em> on a DNA level. <strong>(D)</strong> The consequence ratios predicted for <em>BRCA2</em> on a protein level.</p></figcaption></figure><p>Although there was an enrichment of actionable <em>BRCA2</em> variants in our populations (<a href="#T4" class="usa-link">Table 4</a>), the profile regarding the composition and impact of the variants on DNA and protein level corresponded between the two genes (<a href="#F3" class="usa-link">Figures 3A–D</a>), with the exception that the majority missenses of unknown significance were detected in a functional domain or disordered region. <em>BRCA2</em> did reveal a smaller margin of intronic variants (<a href="#F3" class="usa-link">Figure 3C</a>), as the bulk of non-coding variation was in the 3′ untranslated region. The high percentage of missense variants in the heterozygous form illustrated the unique composition of the SA populations, contributing to the rate of VUSes identified due to a lack of African data in the international context (<a href="#T4" class="usa-link">Table 4</a>).</p></section></section><section id="s4"><h2 class="pmc_sec_title">4 Discussion</h2>
<section id="s4-1"><h3 class="pmc_sec_title">4.1 Targeted Genotyping</h3>
<p>Translational research performed at the University of Free State in collaboration with Professor L Jansen van Rensburg at the University of Pretoria resulted in the identification of the first two recurrent SA pathogenic variants in <em>BRCA1</em>, namely c.1374del (legacy name 1493delC) and c.2641G&gt;T (legacy name E881X) observed for the Afrikaner population. Based on this research, <em>BRCA1</em> c.2641G&gt;T was the first SA pathogenic variant to receive founder status, proven by haplotype analysis that indicated a single mutational event (<a href="#B66" class="usa-link" aria-describedby="B66">Reeves et al., 2004</a>). This variant was soon followed with founder status for <em>BRCA1</em> c.1374del and <em>BRCA2</em> c.7934del (legacy 8162delG). These three founder variants (with <em>BRCA2</em> c.7934del being the most common) were initially restricted to familial BC families with an Afrikaner heritage. Their founder status was corroborated with genealogical evidence dating back over 13 generations. For each variant, a single founding couple was identified based on genealogical findings traced back to France (<em>BRCA1</em> c.2641G&gt;T), the Netherlands (<em>BRCA2</em> c.7934del) and Belgium (<em>BRCA1</em> c.1374del) (<a href="#B66" class="usa-link" aria-describedby="B66">Reeves et al., 2004</a>; <a href="#B84" class="usa-link" aria-describedby="B84">Van der Merwe and van Rensburg, 2009</a>).</p>
<p>The research resulted in the first diagnostic test (entailing screening for the three Afrikaner founder variants) offered to patients in the public sector in 1998. Diagnostic testing was initially restricted to Afrikaner individuals as translational research was performed in parallel to identify pathogenic variants in the other SA population groups (<a href="#B3" class="usa-link" aria-describedby="B3">Agenbag, 2005</a>; <a href="#B74" class="usa-link" aria-describedby="B74">Sluiter and Van Rensburg, 2011</a>; <a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>; <a href="#B64" class="usa-link" aria-describedby="B64">Peter, 2014</a>; <a href="#B16" class="usa-link" aria-describedby="B16">Chen, 2015</a>; <a href="#B20" class="usa-link" aria-describedby="B20">Combrink, 2016</a>; <a href="#B55" class="usa-link" aria-describedby="B55">Moeti, 2016</a>; <a href="#B60" class="usa-link" aria-describedby="B60">Oosthuizen, 2016</a>). With time, various non-Afrikaner recurrent variants had been identified that were proven to represent recurrent variants, which include <em>BRCA2</em> c.5771_5774del (legacy 5999del4) and <em>BRCA2</em> c.582G&gt;A, both Black African founder variants (<a href="#B86" class="usa-link" aria-describedby="B86">Van der Merwe et al., 2012</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>).</p>
<p>As the demand for diagnostic testing increased over the years, patients were collectively tested for the eight most commonly occurring SA variants, irrespective of ethnicity. This mutation set included the three Ashkenazi Jewish/European founder variants based on the African Lemba tribe’s affinity with the Ashkenazi Jews (<a href="#B76" class="usa-link" aria-describedby="B76">Spurdle and Jenkins, 1996</a>) and the SA Indian community to mainland India and Europe (<a href="#B20" class="usa-link" aria-describedby="B20">Combrink, 2016</a>). This targeted genotyping assay served as a first-tier test for all patients that proved justified, because with time, the admixture of the SA populations became evident based on the genotyping results. The founder variants were no longer restricted to a single ethnicity but were shared among groups. This situation was expected, as recently illustrated by the findings of <a href="#B36" class="usa-link" aria-describedby="B36">Hollfelder et al. (2020)</a>. With the use of five million genome-wide markers, 77 Afrikaner individuals were genotyped. Although the bulk of the genetic information represented Europeans, the study indicated a contribution of 1.7% from South Asia or India, 1.3% from the Khoikhoi and the San and 0.8% representing West and East Africa (<a href="#B36" class="usa-link" aria-describedby="B36">Hollfelder et al., 2020</a>).</p>
<p>The results obtained from this series indicate that not all variants currently included in the first-tier genotyping assay are worthy of inclusion due to their low prevalence. This applies to the three Ashkenazi Jewish founder/European variants and <em>BRCA1</em> c.1374del, the rarest Afrikaner founder variant. The maximal financial benefit will be obtained once the first-tier assay has been re-designed to include the most commonly occurring variants in the SA population. It will aid the financially depleted healthcare system by first screening patients for the most common <em>BRCA1/2</em> variants in the population before advancing to more costly NGS (<a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>).</p></section><section id="s4-2"><h3 class="pmc_sec_title">4.2 Epidemiology</h3>
<p>The epidemiology data highlighted three important aspects to be considered for the SA population. The first entailed the relatively high percentage of young individuals (20–29 years) identified with an actionable variant (0.5%, <a href="#T2" class="usa-link">Table 2</a>). Fifty-six percent of the group (<em>n</em> = 62) was unaffected and was referred for carrier testing only. For 22.8% of these individuals, targeted genotyping revealed a positive test result. By knowing their mutation status so early in life, these women were empowered by informed screening decisions and potentially alternative management options. Maximum benefit was therefore gained to reduce their risk of developing cancer types associated with <em>BRCA1/2</em> pathogenic variants. Asymptomatic young mutation carriers can reduce their risk of BC mortality by being regularly monitored and taking up interventions such as preventive surgery and/or chemoprevention (<a href="#B50" class="usa-link" aria-describedby="B50">McCarthy and Armstrong, 2014</a>).</p>
<p>The remainder (44%) of the 20–29 group was affected with early-onset BC (<em>n</em> = 27), with ages at onset ranging from 20 to 29 (average 26.7) years. The patients represented the Black African (<em>n</em> = 15), mixed ancestry (<em>n</em> = 5) and Caucasian (<em>n</em> = 6) ethnicities. Twenty-two percent (<em>n</em> = 6) of these patients received a positive test result (average age at onset 22.5 years), with the majority self-identified as Black African females. Half of these mutation-positive patients presented with a family history of BC and other cancer types, such as prostate cancer, melanoma and pancreatic cancer. Although these females were diagnosed at such a young age, knowing their <em>BRCA1/2</em> status promoted informed decision-making regarding treatment options and potential surgery. With a familial <em>BRCA</em> variant identified so early, cascade testing of related family members can proceed to assist with risk-reducing interventions themselves.</p>
<p>According to the latest clinical guidelines released for BC control and management by the SA Department of Health in 2018 (<a href="#B58" class="usa-link" aria-describedby="B58">National Department of Health of the Republic of South Africa, 2018</a>), all these patients qualified for genetic services, yet the numbers genetically screened are meager (<a href="#T2" class="usa-link">Table 2</a>). With a positive detection rate between 6% and 24%, attention should be drawn to genetic screening, as the benefits would outweigh the financial costs by far (<a href="#T3" class="usa-link">Table 3</a>).</p>
<p>The epidemiological evidence highlighted the ever-important value of a family history as a potential predictor of a positive test result (<a href="#s12" class="usa-link">Supplementary Table S1</a>), as 90% of patients with an actionable <em>BRCA1/2</em> variant reported family members affected with BC and other cancer types. Identifying an actionable <em>BRCA1/2</em> variant in an index acts as a key to the entire family. Once a mutation carrier has been identified, the benefits of genetic testing can be magnified through sharing positive test results with at-risk related family members. Doing so will ensure that they benefit from this information and secure their access to predictive testing according to the latest guidelines. This approach is of tremendous importance from a public health perspective, pushing for improved survival and quality of life through earlier detection and optimal management.</p>
<p>
<a href="#B22" class="usa-link" aria-describedby="B22">Conley et al. (2020)</a> recently investigated the family disclosure patterns of <em>BRCA</em> genetic test results among young Black women with invasive BC in the United States of America. The study examined whether a disclosure to relatives was made, and if so, to whom it was disclosed. The authors reported that the most significant benefit of genetic testing, namely to inform family members of a hereditary predisposition, is not being realized in Black American families. Their findings revealed a reluctance of mutation-positive patients to disclose a positive test result even to their daughters (<a href="#B22" class="usa-link" aria-describedby="B22">Conley et al., 2020</a>).</p>
<p>The reluctance to share genetic test results with family members is also evident in SA. Here it is not restricted to the Black African population but clearly occurs among all ethnic groups in SA apart from the Caucasians. Despite 481 individuals receiving a positive test result, a mere 318 predictive or carrier tests had been performed over 24 years. The majority was performed before 2003 as a post-research initiative involving Afrikaner families. From the epidemiological results, it appeared that Caucasians tended to value and discussed the outcome of genetic testing to a greater extent than the other main ethnic groups (<a href="#T1" class="usa-link">Table 1</a>). This trend was also noted by <a href="#B5" class="usa-link" aria-describedby="B5">Armstrong et al. (2003)</a>, who found that women pursuing <em>BRCA1/2</em> genetic testing in the United States were significantly more likely to be Caucasian.</p>
<p>This issue has been investigated internationally and although the public attitudes towards genetic testing for the risk of diseases, including cancer, are generally positive, various studies highlighted areas of concern. These include factors such as language barriers, fear of discrimination against those with a genetic predisposition for illness (<a href="#B31" class="usa-link" aria-describedby="B31">Haga et al., 2013</a>), being labeled as an individual or family with “good” or “bad” genes (<a href="#B34" class="usa-link" aria-describedby="B34">Henneman et al., 2013</a>) and fatalistic views of cancer (<a href="#B4" class="usa-link" aria-describedby="B4">Allford et al., 2014</a>). In SA, <a href="#B72" class="usa-link" aria-describedby="B72">Schoeman et al. (2013)</a> previously reported a low level of awareness regarding genetic testing for BC and other cancer types. Despite genetic testing being available since 1998, recognizing the value of a predictive test remains low. SA, therefore, needs to investigate innovative approaches to increase awareness among patients and communities, starting with related family members of mutation carriers. As the workforce of genetic providers is extremely low both in SA and globally, the international genetics profession has attempted to adapt to the situation by offering genetic counseling via alternative new methods, including service delivery via telephone, telegenetics and group genetic counseling. Although a face-to-face consultation is always the ideal model to strive for, innovative service delivery models such as group counseling can improve access and contribute to community awareness.</p>
<p>In the paper by <a href="#B48" class="usa-link" aria-describedby="B48">Mampunye et al. (2021)</a>, one such innovation was described for SA, which investigated the clinical value of rapid point-of-care (POC) genetic testing performed in combination with genetic counseling. As the ParaDNA workflow involves an integrated system from sample collection to report generation, prospective validation using a non-invasive cheek swab or saliva as input DNA is warranted (<a href="#B48" class="usa-link" aria-describedby="B48">Mampunye et al., 2021</a>). This approach would be ideal for use as a first-tier test performed by trained healthcare providers in parallel with genetic counseling in rural primary health clinics. This will provide the opportunity to improve the care process by delivering on-demand psychosocial support directly to the patient and indirectly to the community where it is needed. This approach could have many benefits: 1) reducing the lack of early healthcare-seeking due to limited financial resources and transport difficulties; 2) increasing community knowledge and cancer awareness resulting in less stigmatization; 3) creating an opportunity to explain the benefits of knowing your <em>BRCA1/2</em> genetic status for evidence-based cancer treatment options; and 4) highlighting the benefits of testing for at-risk family members in the case of a positive test result, thereby increasing preventative actions and early detection (<a href="#B48" class="usa-link" aria-describedby="B48">Mampunye et al., 2021</a>).</p>
<p>Unfortunately, the burden of BC-related death is ever increasing due to persisting misconceptions surrounding the disease and various other socio-economic factors such as poverty, cultural and religious beliefs (<a href="#B85" class="usa-link" aria-describedby="B85">Van der Merwe et al., 2020</a>; <a href="#B48" class="usa-link" aria-describedby="B48">Mampunye et al., 2021</a>; <a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al., 2021</a>). Despite the efforts of the SA Department of Health’s BC development plan establishing multiple Regional Breast Units (RBUs, 28 distributed throughout the various provinces) at primary and secondary state hospitals, and 14 additional Specialized Breast Units (SBUs) located in mostly tertiary hospitals (<a href="#B58" class="usa-link" aria-describedby="B58">National Department of Health of the Republic of South Africa, 2018</a>), the uptake of breast screening remains low in women 30 years and older (<a href="#B65" class="usa-link" aria-describedby="B65">Phaswana-Mafuya and Peltzer, 2018</a>). The authors of this large study (<em>n</em> = 10,831) estimated a low prevalence of BC screening similar to that obtained in a 2008 survey involving older SA adults, 50 years and older (<a href="#B63" class="usa-link" aria-describedby="B63">Peltzer and Phaswana-Mafuya, 2014</a>). Their estimation corresponded with the prevalence observed in international low-income countries such as Thailand (<a href="#B57" class="usa-link" aria-describedby="B57">Mukem et al., 2016</a>) and Turkey (<a href="#B75" class="usa-link" aria-describedby="B75">Sözmen et al., 2016</a>), but was lower than that of Brazil (<a href="#B80" class="usa-link" aria-describedby="B80">Theme Filha et al., 2016</a>). For SA to advance in this battle and attack BC energetically and effectively, we have to invest in community-health educational out-reaches performed in parallel with highly specialized science to achieve the ultimate goals set for the country.</p>
<p>The epidemiological data finally emphasized the value of screening all OVC patients for actionable variants in <em>BRCA1/2</em>, as screening resulted in a mutation-positive rate of 28.2% (<a href="#s12" class="usa-link">Supplementary Table S3</a>). Nine (45.0%) of the 20 OVC mutation carriers exhibited one of the SA founder variants, with the remainder of actionable variants being family-specific. These founder variants could easily have been identified cost-effectively using first-tier targeted genotyping, before proceeding to comprehensive genetic analysis. A high number of these OVC <em>BRCA1/2</em> mutation carriers, however, was referred for identification of a rare family-specific variant. Although patients affected with OVC before the age of 60 are included in the national clinical guidelines for the control and management of BC (<a href="#B58" class="usa-link" aria-describedby="B58">National Department of Health of the Republic of South Africa, 2018</a>), only 91 OVC patients were received between 1998–2021. This number accounts for 3.9 patients screened per year in the public sector. Currently, the age-standardized incidence rate for OVC in southern Africa is 3.9 per 100,000 (<a href="#B79" class="usa-link" aria-describedby="B79">The Council for Medical Schemes, 2019</a>). Based on these statistics, the majority of OVC patients are currently not referred for any <em>BRCA1/2</em> screening.</p>
<p>Screening these patients could have a two-fold advantage. International ongoing clinical trials involving poly (ADP-ribose) polymerase (PARP) inhibitors have recently resulted in the approval of various inhibitors by the Food and Drug Administration within the US Department of Health and Human Services for clinical use in specifically epithelial OVC patients (<a href="#B46" class="usa-link" aria-describedby="B46">Loizzi et al., 2020</a>). This new therapeutic approach for the management of OVC has been suggested in particular for patients with assessed defects in the homologous recombination DNA repair process such as <em>BRCA1/2</em> (<a href="#B77" class="usa-link" aria-describedby="B77">Sunada et al., 2018</a>; <a href="#B25" class="usa-link" aria-describedby="B25">Elias et al., 2018</a>). By knowing their mutation status, patients will be appropriately selected for this new revolutionary treatment option. Unfortunately, the use of PARP inhibitors is not yet registered by the South African Health Products Regulatory Authority and their use in treatment requires Section 21 approval for the private sector (<a href="#B79" class="usa-link" aria-describedby="B79">The Council for Medical Schemes, 2019</a>). It is currently not available for the clinical treatment of patients in the public sector.</p></section><section id="s4-3"><h3 class="pmc_sec_title">4.3 Mutation Spectrum</h3>
<p>We aimed to describe clinically relevant germline <em>BRCA1/2</em> variants and their distribution across ethnicities in the most extensive unselected African series to date for the public sector. The data represent the current status after 23 years of <em>BRCA</em> testing within our state laboratory. Although testing commenced with a tiered approach in the form of research-based translational targeted genotyping, the total number of test requests and the number of variants identified soared within the past decade. This could be attributed to a heightened public awareness after the Angelina Jolie revelations in 2013 (<a href="#B81" class="usa-link" aria-describedby="B81">Troiano et al., 2017</a>) and the incorporation of NGS into our diagnostic workflow, which enabled a more rapid throughput and resulted in more effective variant discovery.</p>
<p>A total of 481 individuals were identified as high-risk <em>BRCA1/2</em> mutation carriers, with 69.6% (<em>n</em> = 335) representing patients affected by BC and/or OVC, accounting for 9.2% of patients comprehensively screened (132/1,429). The data revealed an extreme distribution for each gene, with only a few frequent pathogenic variants identified. The majority of variants were extremely rare and primarily family-specific (<a href="#T5" class="usa-link">Table 5</a>). Although the proven founder or recurrent variants for the Ashkenazi Jewish, Afrikaner and Black African/mixed ancestry variants were the most common variants observed in terms of the highest frequencies, they only represented &lt;10% of the variants identified (4/55 for <em>BRCA1</em> and 5/57 for <em>BRCA2</em>, <a href="#T5" class="usa-link">Table 5</a>).</p>
<section class="tw xbox font-sm" id="T5"><h4 class="obj_head">TABLE 5.</h4>
<div class="caption p"><p>Actionable <em>BRCA1/2</em> variants (likely- to pathogenic) identified for the entire SA cohort (<em>n</em> = 2,896).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead valign="top"><tr>
<th align="left" rowspan="1" colspan="1">Variant</th>
<th align="center" rowspan="1" colspan="1">Protein</th>
<th align="center" rowspan="1" colspan="1">Cancer type in index or family</th>
<th align="center" rowspan="1" colspan="1">Exon</th>
<th align="center" rowspan="1" colspan="1">#Of families</th>
<th align="center" rowspan="1" colspan="1">rs number</th>
</tr></thead>
<tbody valign="top">
<tr><td colspan="6" align="left" rowspan="1">
<em>
<strong>BRCA1</strong>
</em>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43045584)_(43125327_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">1 – 23</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43123946)_(43125327_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">1 – 2</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43104032)_(43106675_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">4 – 6</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43082330)_(43082599_?)dup</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">12</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43063781)_(43064034_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.11</a>:g.(?_43048992)_(43049260_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.45dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Asn16Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">rs730881457</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.66dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Glu23ArgfsTer18</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">rs80357783</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.68_69del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Glu23ValfsTer17</td>
<td align="center" rowspan="1" colspan="1">BC &amp; Gastric ca</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">rs80357914</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.71G&gt;C</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Cys24Ser</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.110C&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Thr37Lys</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356880</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.135-1G&gt;T</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358158</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.181T&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Cys61Gly</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.191G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Cys64Tyr</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs55851803</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.212G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg71Lys (Splicing defect)</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356913</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.212+1G&gt;A</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356913</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.415C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Gln139Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs80357372</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.431dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Asn144LysfsTer15</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs397509162</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.1016dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Val340LysfsTer6</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80357569</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.1360_1361delAG</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ser454Ter</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">rs80357969</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.1374del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Asp458GlufsTer17</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td align="center" rowspan="1" colspan="1">rs397508862</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.1504_1508delTTAAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Leu502AlafsTer2</td>
<td align="center" rowspan="1" colspan="1">BC &amp; colon ca</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs80357888</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2008G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Glu670Ter</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2070_2073delAAGA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Lys690AsnfsTer10</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2568T&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Tyr856Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356832</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2597G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg866His</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356911</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2599G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Gln867Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs886038001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.2641G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Glu881Ter</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">28</td>
<td align="center" rowspan="1" colspan="1">rs397508988</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3108del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Phe1036LeufsTer12</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80357841</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3228_3229delAG</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Gly1077AlafsTer8</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs80357635</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3288_3289delAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Leu1098SerfsTer4</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80357686</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3331_3334delCAAG</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Gln1111AsnfsTer5</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80357701</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3400G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Glu1134Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3496_3497insT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ala1166ValfsTer2</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3549_3550delAGinsT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Lys1183AsnfsTer27</td>
<td align="center" rowspan="1" colspan="1">Male BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs273899709</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3593T&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Leu1198Ter</td>
<td align="center" rowspan="1" colspan="1">Male BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs397509095</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3732_3733delTA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.His1244GlnfsTer10</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3756_3759delGTCT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ser1253ArgfsTer10</td>
<td align="center" rowspan="1" colspan="1">BC &amp; Melanoma</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs80357868</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.3947_3950delTCTT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Phe1316Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs886040177</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4308_4309delTT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ser1437CysfsTer3</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">12</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4327C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1443Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">12</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs41293455</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4524G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Trp1508Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80356885</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4838_4839insC</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Pro1614SerfsTer8</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs397509200</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4868C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ala1623Val</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">15</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.4987-5T&gt;A</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">16</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs397509214</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5095C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1699Trp</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs55770810</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5096G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1699Gln</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs41293459</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5177_5180delGAAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1726LysfsTer3</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80357867</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5229_5230delAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1744LysfsTer85</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">rs80357852</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5240_5243delGAAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Arg1747LysfsTer3</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5266dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Gln1756ProfsTer74</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">19</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">rs80357906</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5332+1G&gt;C</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358041</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5365_5366delGCinsA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_009225.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_009225.1</a>: p.Ala1789IlefsTer4</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5467+2T&gt;G</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs80358009</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.4</a>(BRCA1): c.5468-1G&gt;A</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358048</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Total</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">
<strong>143</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr><td colspan="6" align="left" rowspan="1">
<em>
<strong>BRCA2</strong>
</em>
</td></tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000013.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000013.11</a>:g.(?_32313776)_(32398795_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">1 – 27</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000013.11" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000013.11</a>:g.(?_32370334)_(32371115_?)del</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">19 – 20</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.67+3A&gt;G</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC, Fanconi anemia</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs1593880835</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.93G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Trp31Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359214</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.516G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Lys172=</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs80359790</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.582G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Trp194Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">7</td>
<td align="center" rowspan="1" colspan="1">13</td>
<td align="center" rowspan="1" colspan="1">rs80358810</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.771_775delTCAAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Asn257LysfsTer17</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359671</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.1261C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Gln421Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358419</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.1813dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ile605AsnfsTer11</td>
<td align="center" rowspan="1" colspan="1">Male BC</td>
<td align="center" rowspan="1" colspan="1">10</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359308</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.2636_2637delCT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser879Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs276174826</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.2806_2809delAAAC</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ala938ProfsTer21</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359351</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.2826_2829delAATT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ile943LysfsTer16</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs397507643</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.2828_2831delTTAA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ile943LysfsTer16</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs397507643</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.3553dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Thr1185AsnfsTer3</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.3723del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Phe1241LeufsTer18</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs886040491</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.3847del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Val1283LysfsTer2</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359405</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.3881T&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Leu1294Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358632</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.4003G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Glu1335Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs747070579</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.4456del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Val1486LeufsTer6</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.4482_4483insAAAG</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser1494LysfsTer20</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.4568del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Gly1523ValfsTer20</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.4936G&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Glu1646Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs886038111</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5082dup</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Glu1695ArgfsTer5</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5213_5216delCTTA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Thr1738IlefsTer2</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs80359493</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5279C&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser1760Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358751</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5344C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Gln1782Ter</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80358757</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5564C&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser1855Ter</td>
<td align="center" rowspan="1" colspan="1">OVC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5771_5774delTTCA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ile1924ArgfsTer38</td>
<td align="center" rowspan="1" colspan="1">Male BC, BC, OVC, prostate ca, endometrial ca, Fanconi aneamia</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">61</td>
<td align="center" rowspan="1" colspan="1">rs80359535</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.5946del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser1982ArgfsTer22</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">rs80359550</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6082_6086delGAAGA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Glu2028LysfsTer19</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359558</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6228del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Lys2077ArgfsTer4</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6393_6396delATTA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Lys2131AsnfsTer5</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs397507849</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6393del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Lys2131AsnfsTer6</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs886038145</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6447_6448dupTA</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Lys2150IlefsTer19</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">rs397507858</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6623del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Asn2208IlefsTer2</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">11</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs886038150</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.6937+2delT</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">12</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.7934del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Arg2645AsnfsTer3</td>
<td align="center" rowspan="1" colspan="1">Male BC, BC, OVC, prostate cancer, melanoma</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">176</td>
<td align="center" rowspan="1" colspan="1">rs80359688</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.7955T&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Val2952Gly</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">17</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs1555286868</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8067T&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Cys2689Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">rs80359046</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8165C&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Thr2722Arg</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359062</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8167G&gt;C</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Asp2723His</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs41293511</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8168A&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Asp2723Val</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs41293513</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8331+2T&gt;C</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs309122602</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8504C&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser2835Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">18</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs80359102</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8686del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Arg2896ValfsTer13</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8696_8712del17</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Gln2899LeufsTer2</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8754+1G&gt;A</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">21</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">rs397508006</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8954-2A&gt;C</td>
<td align="left" rowspan="1" colspan="1">Splicing defect</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs1135401928</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.8961_8964delGAGT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser2988PhefsTer12</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">rs80359734</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9105T&gt;G</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Tyr3035Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">rs886040819</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9117G&gt;A</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Pro3039= (Splicing defect)</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">23</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs28897756</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9138del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Gln3047ArgfsTer15</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">24</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9154C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Arg3052Trp</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">24</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">rs45580035</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9351del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.His3117GlnfsTer3</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9382C&gt;T</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Arg3128Ter</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9833_9842del</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Pro3278HisfsTer32</td>
<td align="center" rowspan="1" colspan="1">BC</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">no rs</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.4</a>(BRCA2): c.9435_9436delGT</td>
<td align="left" rowspan="1" colspan="1">
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.3</a>: p.Ser3147CysfsTer2</td>
<td align="center" rowspan="1" colspan="1">BC &amp; OVC</td>
<td align="center" rowspan="1" colspan="1">25</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">rs80359763</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Total</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="center" rowspan="1" colspan="1">
<strong>342</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Both the number of variants and their mutation spectrum differed for the various population groups. From the NGS data, it seemed as if the Black African group (<em>n</em> = 479) exhibited the largest diversity in both actionable and novel variants (44/479), as approximately double the number of variants were observed compared to the other groups (Asians 12/180; Caucasians 25/138; mixed ancestry 22/167 and individuals of unknown ethnicity 14/118). These numbers, however, do not accurately reflect the contribution of pathogenic variants to this group, as considerably more Black African patients were tested (at a ratio of approximately 3:1). Despite their higher diversity of pathogenic variants, the Black African group had the second-lowest positive detection rate (9.2%), apart from the Asian population with 6.6%. This can partly be attributed to patients being referred for genetic testing based on an early age at diagnosis alone, as most Black African patients were unaware of the accumulation of cancer occurrences in their families. In contrast, the Caucasian population exhibited the highest detection rate, namely 18.1%, despite a much lower number of patients tested using NGS. These patients seemed to be more appropriately selected as the majority of patients reported an intermediate to strong family history of BC and/or OVC. As the majority of mutation-positive patients carried one of the Afrikaner founder variants, the contribution of the Afrikaner founder variants to this group was evident.</p>
<p>The Caucasian and Black African detection rates declined from 18.1% to 9.2% to an overall 10% and 6.6%, respectively, once the founder variants detected during NGS were excluded. This finding indicates an ultimate positive mutation detection rate below 10% for NGS, which is currently not cost-effective. If these patients were screened using the first-tier targeted genotyping assay, costs could have been reduced by excluding these patients prior to NGS analysis. The difference in the positive detection rate between these two ethnic groups with well-characterized variants iterates the importance of family history and genetic cancer registries. By updating these registries, testing centers can keep track of related family members carrying actionable familial <em>BRCA1/2</em> variants, with the sole purpose to identify at-risk symptomatic-free family members.</p>
<p>This study attempted to report the mutation detection rates over the past two decades from a single institutional series’ perspective, with some biases due to: 1) the various techniques used; 2) disproportionate numbers of multiple ethnic groups studied; and 3) the minimum clinical criteria for BRCA testing changing. Therefore, the mutation detection rates presented per ethnic group does not accurately represent the positive predictive value of each technique and the national mutational burden of the respective groups. It merely reflects the frequencies of actionable variants detected at the time and within the performance specifications regarding the sensitivity and specificity of each mutation screening technique. The genotyping approach only identified selected pathogenic variants and did not enable the reporting of VUSes. Compared to NGS, screening for pathogenic variants using HRMA could have missed pathogenic variants and VUSes due to possible inadequate sensitivity during melt curve analysis in suboptimal PCR conditions (despite rigorous optimization and running each reaction in duplicate) (<a href="#B20" class="usa-link" aria-describedby="B20">Combrink, 2016</a>; <a href="#B60" class="usa-link" aria-describedby="B60">Oosthuizen, 2016</a>). In addition to a potential reduction in sensitivity of HRMA, the largest exons namely exon 10 of <em>BRCA1</em> and exons 10 and 11 of <em>BRCA2</em> were screened for protein-truncating variants only using PTT. The technique would therefore have missed various missense, synonymous or splice-site variants which could have represented actionable variants.</p>
<p>Sanger sequencing was utilized only for the confirmation of variants detected using the various mutation screening techniques. It was therefore not employed in this series for sequencing entire coding regions and splice site boundaries of samples. Moreover, biases in the detection frequencies of ethnic groups could have been introduced due to the disproportionate number of individuals in each group being screened with NGS, the most modern and sensitive technique in the test repertoire. Lastly, the criteria for <em>BRCA1/2</em> screening broadened with time and became more inclusive throughout the decades with more individuals currently meeting criteria than did a decade or two ago.</p>
<p>This series represents the most extensive report involving the <em>BRCA1/2</em> mutation spectrum on the African continent, surpassing the Nigerian study involving 1,136 patients (<a href="#s12" class="usa-link">Supplementary Table S4</a>). The positive mutation rate, however, was similar (9.2% versus a collective 11.1% in Nigeria), although the contribution of the genes was reversed, with <em>BRCA2</em> being more prevalent in SA (<a href="#s12" class="usa-link">Supplementary Table S4</a>). This observation can be attributed to the prevalence of three SA founder variants in <em>BRCA2</em>, representing three of the four SA ethnic groups (Black African, Caucasian and mixed ancestry groups). Although some African countries reported extremely high <em>BRCA1/2</em> mutation-positive rates above 15% (such as Egypt, Morocco, SA, Sudan and Tunisia), the majority of African studies involved small sample sizes based on very strict selection criteria.</p>
<p>Twenty-seven of the actionable variants were novel, with no unique identifier listed. The total number of novel variants increased when the complete variant list was considered (including benign variants to VUSes), with most present in a heterozygous form (<a href="#T4" class="usa-link">Table 4</a>). These novel variants were mostly observed for the Black African group, which was expected due to the high degree of variation evident in the African genome when compared to that of the Asian, African-American and European genomes. Recent genomic studies (<a href="#B19" class="usa-link" aria-describedby="B19">Choudhury et al., 2020</a>) revealed the presence of more than 3 million previously undescribed variants and predicted that only a fraction of the genetic diversity among individuals on the African continent has thus far been uncovered. This study exposed complex patterns of ancestral admixture, as both intra- and inter-population variations were observed. Although the authors did not observe a multitude of pathogenic variants in medically relevant genes, a significant number of variants denoted as likely-pathogenic in other genes were present in the ClinVar database (<a href="#B19" class="usa-link" aria-describedby="B19">Choudhury et al., 2020</a>). Such a high degree of genomic variation complicates the general approach of Mendelian classifications for variant interpretation, as for many variants, the MAF is either not known or very low, immediately classifying them as a rare variant, possibly also absent from population databases such as GnomAD and others.</p>
<p>This complexity highlights the necessity of functional assays performed in parallel with haplotype analysis. Haplotype inference for SA based on NGS data was performed by <a href="#B61" class="usa-link" aria-describedby="B61">Oosthuizen et al. (2021)</a>. The authors reported several variants at low frequency to be in linkage disequilibrium in specific SA population groups, which emphasized the importance of long-range PCR confirmation for phasing. Suspected benign missense variants co-segregating with pathogenic variants or SNV-based VUSes, albeit at a low frequency, could act as potential modifiers regarding disease penetrance. Even subtle influences such as these can possibly contribute to the value of risk scores unique to population groups.</p>
<p>Collectively, these factors contribute to variants not being fully classified as actionable due to a lack of evidence (using the ACMG classification criteria). This resulted in potentially actionable variants currently classified as VUSes because of a paucity of evidence in the international literature. Finally, despite the increase in throughput and the extended scope for <em>BRCA1/2</em> variant discovery, less than 10% of patients with a personal history of cancer diagnosed at an early age, or who had a positive family history, received a positive test result, leaving the remainder of patients still in the dark regarding alternative management and therapeutic options involving poly (ADP-ribose) (PARP) inhibitors. As various other genes associated with <em>BRCA1/2</em> have been indicated to contribute to homologous recombination and DNA repair (such as ATM Serine/Threonine Kinase [<em>ATM</em>], BRCA1 Interacting Helicase I [<em>BRIP1</em>], Checkpoint Kinase 2 [<em>CHEK2</em>], RAD51 Paralog C [<em>RAD51C</em>] and Partner And Localizer of BRCA2 [<em>PALB2</em>]), the search for actionable variants responsible for hereditary BC and/or OVC needs to be expanded. With NGS already implemented, we propose moving towards multigene panel testing in the future. It could result in the identification of additional role players contributing to the disease burden in SA. By performing multipanel testing, we will be able to identify deleterious variants in multiple cancer susceptibility genes, which will allow us to identify eligible patients and related family members for clinical interventions, surveillance screening, targeted therapy and potential prevention strategies, according to the National Comprehensive Cancer Network (NCCN) guidelines.</p></section></section><section id="s5"><h2 class="pmc_sec_title">5 Conclusion</h2>
<p>The vision of better health systems for African countries is encompassed in the health-related sustainable development goals set by the World Health Organization (WHO) for Africa in 2018 (<a href="#B88" class="usa-link" aria-describedby="B88">World Health Organization Africa, 2021</a>). The SA Department of Health has recognized this initiative and pledged to reform this critical sector by releasing updated clinical guidelines for BC management and control during the same year. With the advances made in genetic testing for familial BC and OVC in state laboratories in SA, it has the potential to contribute immensely to the identification of high-risk <em>BRCA1/2</em> and non-<em>BRCA</em> germline actionable variants in patients. Given the magnitude of the disease, knowing a patient’s mutation status can aid in the individualization of their treatment, which is of great benefit for the attending physician as it contributes to the patient’s overall survival and will be of importance for related family members.</p>
<p>Due to the potential and far-reaching impact genetic testing has on augmenting the risk in a family with a positive family history of BC and/or OVC or in a patient diagnosed at an early age, it is imperative that the search is broadened to include other non-<em>BRCA</em> genes. Together, all these genes play an integral role in multiple signaling pathways inside the cell, with crosstalk between the associated proteins. If one of these signaling molecules becomes nonfunctional, the balance could be disturbed and may contribute to the progression of carcinogenesis.</p>
<p>The large number of novel and the abundance of heterozygous variants detected in this series reflect a high degree of genomic diversity. This highlights the existence of an immense gap in available naturally occurring population-specific knowledge due to a lack of African genomes in public genetic archives. Many diagnostic laboratories rely heavily on MAF and <em>in silico</em> predictions for variant interpretation and classification. In SA, as in many other African countries, this gap results in an unfavorable amount of VUSes classified. The lack of reference genomes increases the struggle to keep up with the rapid evolution in genetic variant screening for the confirmation of diagnosis. Although major strides have been made in the past decade in an attempt to catch up with first-world countries, uptake of genetic diagnostic services will not reach its full potential unless it becomes more affordable and a substantial number of African genomes is available to assist with variant interpretation and classification.</p>
<p>The SA scientific community is therefore compelled to continue with translational research in order to adopt first-world technologies into its healthcare context as a developing country. The vast progress made over the past two decades enabled a vital shift away from population-directed genetic testing to potentially comprehensive screening for all BC and OVC cancer patients. Consequently, the medical and scientific community in SA will continuously strive to comply with international standards and guidelines aimed at universal healthcare for all patients regardless of ethnicity, financial status or continent of birth. For centuries, the people of Africa have been marginalized and disadvantaged in many aspects, including optimal health care. With the WHO focusing on Africa, the health and well-being of its people are improving, resulting in the people of Africa currently sharing a vision for the future that is filled with optimism and hope.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors acknowledge all previous postgraduate students and medical scientists that participated in the translational research phase of the project or who were directly involved with the testing, namely N. Peter (MMedSc and NHLS Intern Medical Scientist), P. Moeti (MMedSc), C. Schultz, B. Dajee and A. Diedericks. Dr. Daleen Struwig, medical writer/editor, Faculty of Health Sciences, University of the Free State, for the final language editing of the manuscript.</p></section><section id="s6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#s12" class="usa-link">Supplementary Material</a>.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by the Health Sciences Research Ethics Committee Faculty of Health Sciences University of the Free State. The patients/participants provided their written informed consent to participate in this study.</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>NM, JO, and HC made substantial contributions to the conception, design, and completion of this publication. NM obtained the ethics approvals and selected the data for inclusion. JO, HC, KN, and NM performed the genetic studies together with previous medical scientists involved in <em>BRCA</em> testing in this NHLS laboratory over the years. NM, JO and HC were responsible for the optimization of various techniques utilized. KN reviewed all the request forms for the collation of data and assisted with the population of an in-house database designed by HC. NM framed the study in relation to past achievements. All authors contributed to the article and approved the submitted version.</p></section><section id="s9"><h2 class="pmc_sec_title">Funding</h2>
<p>The translational research performed between 1995–2020 was supported by the South African Medical Research Council (SAMRC—self-initiated research grant 2012), with funds also received from the National Health Laboratory Service Research Trust (NHLSRT—2008, 2011, 2013, 2016, 2017) and the National Research Foundation (NRF—98291, 92192).</p></section><section id="s10"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s11"><h2 class="pmc_sec_title">Publisher’s Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="s12"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2022.834265/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fgene.2022.834265/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM2"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table2.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM3"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table3.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM4"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table4.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (23.7KB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="B1">
<cite>
AbdelHamid S. G., Zekri A.-R. N., AbdelAziz H. M., El-Mesallamy H. O. (2021). 
<em>BRCA1</em> and <em>BRCA2</em> Truncating Mutations and Variants of Unknown Significance in Egyptian Female Breast Cancer Patients. Clinica Chim. Acta
512, 66–73. 10.1016/j.cca.2020.11.023
</cite> [<a href="https://doi.org/10.1016/j.cca.2020.11.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33278427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinica%20Chim.%20Acta&amp;title=BRCA1%20and%20BRCA2%20Truncating%20Mutations%20and%20Variants%20of%20Unknown%20Significance%20in%20Egyptian%20Female%20Breast%20Cancer%20Patients&amp;author=S.%20G.%20AbdelHamid&amp;author=A.-R.%20N.%20Zekri&amp;author=H.%20M.%20AbdelAziz&amp;author=H.%20O.%20El-Mesallamy&amp;volume=512&amp;publication_year=2021&amp;pages=66-73&amp;pmid=33278427&amp;doi=10.1016/j.cca.2020.11.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<cite>
Adedokun B., Zheng Y., Ndom P., Gakwaya A., Makumbi T., Zhou A. Y., et al.  (2020). Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes Among Women in Uganda and Cameroon. Cancer Epidemiol. Biomarkers Prev.
29, 359–367. 10.1158/1055-9965.EPI-19-0506
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-19-0506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7007381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31871109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomarkers%20Prev.&amp;title=Prevalence%20of%20Inherited%20Mutations%20in%20Breast%20Cancer%20Predisposition%20Genes%20Among%20Women%20in%20Uganda%20and%20Cameroon&amp;author=B.%20Adedokun&amp;author=Y.%20Zheng&amp;author=P.%20Ndom&amp;author=A.%20Gakwaya&amp;author=T.%20Makumbi&amp;volume=29&amp;publication_year=2020&amp;pages=359-367&amp;pmid=31871109&amp;doi=10.1158/1055-9965.EPI-19-0506&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<cite>
Agenbag G. (2005). Molecular Genetic Analysis of Familial Breast Cancer in South Africa. Stellenbosch: MSc dissertationUniversity of Stellenbosch. Available at: <a href="https://scholar.sun.ac.za/handle/10019.1/1521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scholar.sun.ac.za/handle/10019.1/1521</a> (Accessed November 16, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Molecular%20Genetic%20Analysis%20of%20Familial%20Breast%20Cancer%20in%20South%20Africa&amp;author=G.%20Agenbag&amp;publication_year=2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<cite>
Allford A., Qureshi N., Barwell J., Lewis C., Kai J. (2014). What Hinders Minority Ethnic Access to Cancer Genetics Services and what May Help?
Eur. J. Hum. Genet.
22, 866–874. 10.1038/ejhg.2013.257
</cite> [<a href="https://doi.org/10.1038/ejhg.2013.257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4060110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24253862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=What%20Hinders%20Minority%20Ethnic%20Access%20to%20Cancer%20Genetics%20Services%20and%20what%20May%20Help?&amp;author=A.%20Allford&amp;author=N.%20Qureshi&amp;author=J.%20Barwell&amp;author=C.%20Lewis&amp;author=J.%20Kai&amp;volume=22&amp;publication_year=2014&amp;pages=866-874&amp;pmid=24253862&amp;doi=10.1038/ejhg.2013.257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<cite>
Armstrong K., Weber B., Stopfer J., Calzone K., Putt M., Coyne J., et al.  (2003). Early Use of Clinical <em>BRCA1/2</em> Testing: Associations with Race and Breast Cancer Risk. Am. J. Med. Genet.
117A, 154–160. 10.1002/ajmg.a.10928
</cite> [<a href="https://doi.org/10.1002/ajmg.a.10928" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12567413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Med.%20Genet.&amp;title=Early%20Use%20of%20Clinical%20BRCA1/2%20Testing:%20Associations%20with%20Race%20and%20Breast%20Cancer%20Risk&amp;author=K.%20Armstrong&amp;author=B.%20Weber&amp;author=J.%20Stopfer&amp;author=K.%20Calzone&amp;author=M.%20Putt&amp;volume=117A&amp;publication_year=2003&amp;pages=154-160&amp;pmid=12567413&amp;doi=10.1002/ajmg.a.10928&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<cite>
Ashour M., Ezzat Shafik H. (2019). Frequency of Germline Mutations in <em>BRCA1</em> and <em>BRCA2</em> in Ovarian Cancer Patients and Their Effect on Treatment Outcome. Cmar
Vol. 11, 6275–6284. 10.2147/CMAR.S206817
</cite> [<a href="https://doi.org/10.2147/CMAR.S206817" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6626894/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31372034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cmar&amp;title=Frequency%20of%20Germline%20Mutations%20in%20BRCA1%20and%20BRCA2%20in%20Ovarian%20Cancer%20Patients%20and%20Their%20Effect%20on%20Treatment%20Outcome&amp;author=M.%20Ashour&amp;author=H.%20Ezzat%20Shafik&amp;volume=Vol.%2011&amp;publication_year=2019&amp;pages=6275-6284&amp;pmid=31372034&amp;doi=10.2147/CMAR.S206817&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<cite>
Attlee M. (1947). The Coloured People of South Africa. Afr. Aff.
46, 148–151. 10.1093/oxfordjournals.afraf.a093570
</cite> [<a href="https://doi.org/10.1093/oxfordjournals.afraf.a093570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Afr.%20Aff.&amp;title=The%20Coloured%20People%20of%20South%20Africa&amp;author=M.%20Attlee&amp;volume=46&amp;publication_year=1947&amp;pages=148-151&amp;doi=10.1093/oxfordjournals.afraf.a093570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<cite>
Awadelkarim K. D., Aceto G., Veschi S., Elhaj A., Morgano A., Mohamedani A. A., et al.  (2007). 
<em>BRCA1</em> and <em>BRCA2</em> Status in a Central Sudanese Series of Breast Cancer Patients: Interactions with Genetic, Ethnic and Reproductive Factors. Breast Cancer Res. Treat.
102, 189–199. 10.1007/s10549-006-9303-z
</cite> [<a href="https://doi.org/10.1007/s10549-006-9303-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17333343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=BRCA1%20and%20BRCA2%20Status%20in%20a%20Central%20Sudanese%20Series%20of%20Breast%20Cancer%20Patients:%20Interactions%20with%20Genetic,%20Ethnic%20and%20Reproductive%20Factors&amp;author=K.%20D.%20Awadelkarim&amp;author=G.%20Aceto&amp;author=S.%20Veschi&amp;author=A.%20Elhaj&amp;author=A.%20Morgano&amp;volume=102&amp;publication_year=2007&amp;pages=189-199&amp;pmid=17333343&amp;doi=10.1007/s10549-006-9303-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<cite>
Bakkach J., Mansouri M., Derkaoui T., Loudiyi A., El Fahime E., Barakat A., et al.  (2020). Contribution of BRCA1 and BRCA2 Germline Mutations to Early Onset Breast Cancer: a Series from north of Morocco. BMC Cancer
20, 859. 10.1186/s12885-020-07352-9
</cite> [<a href="https://doi.org/10.1186/s12885-020-07352-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7487731/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32894085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Contribution%20of%20BRCA1%20and%20BRCA2%20Germline%20Mutations%20to%20Early%20Onset%20Breast%20Cancer:%20a%20Series%20from%20north%20of%20Morocco&amp;author=J.%20Bakkach&amp;author=M.%20Mansouri&amp;author=T.%20Derkaoui&amp;author=A.%20Loudiyi&amp;author=E.%20El%20Fahime&amp;volume=20&amp;publication_year=2020&amp;pages=859&amp;pmid=32894085&amp;doi=10.1186/s12885-020-07352-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<cite>
Ben Ayed-Guerfali D., Ben Kridis-Rejab W., Ammous-Boukhris N., Ayadi W., Charfi S., Khanfir A., et al.  (2021). Novel and Recurrent <em>BRCA1/BRCA2</em> Germline Mutations in Patients with Breast/ovarian Cancer: a Series from the South of Tunisia. J. Transl Med.
19, 108. 10.1186/s12967-021-02772-y
</cite> [<a href="https://doi.org/10.1186/s12967-021-02772-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7962399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33726785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Transl%20Med.&amp;title=Novel%20and%20Recurrent%20BRCA1/BRCA2%20Germline%20Mutations%20in%20Patients%20with%20Breast/ovarian%20Cancer:%20a%20Series%20from%20the%20South%20of%20Tunisia&amp;author=D.%20Ben%20Ayed-Guerfali&amp;author=W.%20Ben%20Kridis-Rejab&amp;author=N.%20Ammous-Boukhris&amp;author=W.%20Ayadi&amp;author=S.%20Charfi&amp;volume=19&amp;publication_year=2021&amp;pages=108&amp;pmid=33726785&amp;doi=10.1186/s12967-021-02772-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<cite>
Bensam M., Hafez E., Awad D., El-Saadani M., Balbaa M. (2014). Detection of New Point Mutations of <em>BRCA1</em> and <em>BRCA2</em> in Breast Cancer Patients. Biochem. Genet.
52, 15–28. 10.1007/s10528-013-9623-810.1007/s10528-013-9623-8
</cite> [<a href="https://doi.org/10.1007/s10528-013-9623-810.1007/s10528-013-9623-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23877192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Genet.&amp;title=Detection%20of%20New%20Point%20Mutations%20of%20BRCA1%20and%20BRCA2%20in%20Breast%20Cancer%20Patients&amp;author=M.%20Bensam&amp;author=E.%20Hafez&amp;author=D.%20Awad&amp;author=M.%20El-Saadani&amp;author=M.%20Balbaa&amp;volume=52&amp;publication_year=2014&amp;pages=15-28&amp;pmid=23877192&amp;doi=10.1007/s10528-013-9623-810.1007/s10528-013-9623-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<cite>
Biancolella M., Ouédraogo N. L. M., Zongo N., Zohoncon T. M., Testa B., Rizzacasa B., et al.  (2021). Breast Cancer in West Africa: Molecular Analysis of <em>BRCA</em> Genes in Early-Onset Breast Cancer Patients in Burkina Faso. Hum. Genomics
15, 65. 10.1186/s40246-021-00365-w
</cite> [<a href="https://doi.org/10.1186/s40246-021-00365-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8557567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34717758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genomics&amp;title=Breast%20Cancer%20in%20West%20Africa:%20Molecular%20Analysis%20of%20BRCA%20Genes%20in%20Early-Onset%20Breast%20Cancer%20Patients%20in%20Burkina%20Faso&amp;author=M.%20Biancolella&amp;author=N.%20L.%20M.%20Ou%C3%A9draogo&amp;author=N.%20Zongo&amp;author=T.%20M.%20Zohoncon&amp;author=B.%20Testa&amp;volume=15&amp;publication_year=2021&amp;pages=65&amp;pmid=34717758&amp;doi=10.1186/s40246-021-00365-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<cite>
Boulenouar A. C. S., Coulet F., Bendiab F. M. T., Boudinar F. Z., Senhadji R. (2018). BRCA1 and BRCA2 Germline Mutation Screening in Western Algeria Using High Resolution Melting Analysis (HRM). Gulf J. Oncolog
1, 31–37. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/30145549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gulf%20J.%20Oncolog&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutation%20Screening%20in%20Western%20Algeria%20Using%20High%20Resolution%20Melting%20Analysis%20(HRM)&amp;author=A.%20C.%20S.%20Boulenouar&amp;author=F.%20Coulet&amp;author=F.%20M.%20T.%20Bendiab&amp;author=F.%20Z.%20Boudinar&amp;author=R.%20Senhadji&amp;volume=1&amp;publication_year=2018&amp;pages=31-37&amp;pmid=30145549&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<cite>
Brandt T., Sack L. M., Arjona D., Tan D., Mei H., Cui H., et al.  (2020). Adapting ACMG/AMP Sequence Variant Classification Guidelines for Single-Gene Copy Number Variants. Genet. Med.
22, 336–344. 10.1038/s41436-019-0655-2
</cite> [<a href="https://doi.org/10.1038/s41436-019-0655-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31534211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Adapting%20ACMG/AMP%20Sequence%20Variant%20Classification%20Guidelines%20for%20Single-Gene%20Copy%20Number%20Variants&amp;author=T.%20Brandt&amp;author=L.%20M.%20Sack&amp;author=D.%20Arjona&amp;author=D.%20Tan&amp;author=H.%20Mei&amp;volume=22&amp;publication_year=2020&amp;pages=336-344&amp;pmid=31534211&amp;doi=10.1038/s41436-019-0655-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<cite>
Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. (2018). Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 countriesErratum in. Ca: A. Cancer J. CliniciansCA Cancer J Clin
6870, 394313–394424. 10.3322/caac.21492
</cite> [<a href="https://doi.org/10.3322/caac.21492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ca:%20A.%20Cancer%20J.%20CliniciansCA%20Cancer%20J%20Clin&amp;title=Global%20Cancer%20Statistics%202018:%20GLOBOCAN%20Estimates%20of%20Incidence%20and%20Mortality%20Worldwide%20for%2036%20Cancers%20in%20185%20countriesErratum%20in&amp;author=F.%20Bray&amp;author=J.%20Ferlay&amp;author=I.%20Soerjomataram&amp;author=R.%20L.%20Siegel&amp;author=L.%20A.%20Torre&amp;volume=6870&amp;publication_year=2018&amp;pages=394313-394424&amp;pmid=30207593&amp;doi=10.3322/caac.21492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<cite>
Chen W. (2015). The Molecular Aetiology of Inherited Breast Cancer in the South African Black populationMScMed Dissertation. Johannesburg: University of the Witwatersrand. Available at: <a href="http://hdl.handle.net/10539/19755" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://hdl.handle.net/10539/19755</a> (Accessed September 11, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=The%20Molecular%20Aetiology%20of%20Inherited%20Breast%20Cancer%20in%20the%20South%20African%20Black%20populationMScMed%20Dissertation&amp;author=W.%20Chen&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<cite>
Cherbal F., Bakour R., Adane S., Boualga K., Benais-Pont G., Maillet P. (2010). BRCA1andBRCA2Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families. Dis. Markers
28, 377–384. 10.1155/2010/585278
</cite> [<a href="https://doi.org/10.1155/2010/585278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3833328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20683152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis.%20Markers&amp;title=BRCA1andBRCA2Germline%20Mutations%20Screening%20in%20Algerian%20Breast/Ovarian%20Cancer%20Families&amp;author=F.%20Cherbal&amp;author=R.%20Bakour&amp;author=S.%20Adane&amp;author=K.%20Boualga&amp;author=G.%20Benais-Pont&amp;volume=28&amp;publication_year=2010&amp;pages=377-384&amp;pmid=20683152&amp;doi=10.1155/2010/585278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<cite>
Chistiakov D. A., Voronova N. V., Chistiakov P. A. (2008). Genetic Variations in DNA Repair Genes, Radiosensitivity to Cancer and Susceptibility to Acute Tissue Reactions in Radiotherapy-Treated Cancer Patients. Acta Oncologica
47, 809–824. 10.1080/02841860801885969
</cite> [<a href="https://doi.org/10.1080/02841860801885969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18568480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncologica&amp;title=Genetic%20Variations%20in%20DNA%20Repair%20Genes,%20Radiosensitivity%20to%20Cancer%20and%20Susceptibility%20to%20Acute%20Tissue%20Reactions%20in%20Radiotherapy-Treated%20Cancer%20Patients&amp;author=D.%20A.%20Chistiakov&amp;author=N.%20V.%20Voronova&amp;author=P.%20A.%20Chistiakov&amp;volume=47&amp;publication_year=2008&amp;pages=809-824&amp;pmid=18568480&amp;doi=10.1080/02841860801885969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<cite>
Choudhury A., Aron S., Botigué L. R., Sengupta D., Botha G., Bensellak T., et al.  (2020). High-depth African Genomes Inform Human Migration and Health. Nature
586, 741–748. 10.1038/s41586-020-2859-7
</cite> [<a href="https://doi.org/10.1038/s41586-020-2859-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7759466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33116287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=High-depth%20African%20Genomes%20Inform%20Human%20Migration%20and%20Health&amp;author=A.%20Choudhury&amp;author=S.%20Aron&amp;author=L.%20R.%20Botigu%C3%A9&amp;author=D.%20Sengupta&amp;author=G.%20Botha&amp;volume=586&amp;publication_year=2020&amp;pages=741-748&amp;pmid=33116287&amp;doi=10.1038/s41586-020-2859-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<cite>
Combrink H. (2016). Molecular Screening of the South African Indian Population for <em>BRCA1</em> and <em>BRCA2</em> Using High-Resolution Melting Analysis. M.Med.Sc. Dissertation. Bloemfontein: University of the Free State; 
. <a href="http://hdl.handle.net/11660/4563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://hdl.handle.net/11660/4563</a> (Accessed September 14, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Molecular%20Screening%20of%20the%20South%20African%20Indian%20Population%20for%20BRCA1%20and%20BRCA2%20Using%20High-Resolution%20Melting%20Analysis&amp;author=H.%20Combrink&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<cite>
Combrink H. M., Oosthuizen J., Visser B., Chabilal N., Buccimazza I., Foulkes W. D., et al.  (2021). Mutations in <em>BRCA</em>-Related Breast and Ovarian Cancer in the South African Indian Population: a Descriptive Study. Cancer Genet.
258-259, 1–6. 10.1016/j.cancergen.2021.06.002
</cite> [<a href="https://doi.org/10.1016/j.cancergen.2021.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34218100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet.&amp;title=Mutations%20in%20BRCA-Related%20Breast%20and%20Ovarian%20Cancer%20in%20the%20South%20African%20Indian%20Population:%20a%20Descriptive%20Study&amp;author=H.%20M.%20Combrink&amp;author=J.%20Oosthuizen&amp;author=B.%20Visser&amp;author=N.%20Chabilal&amp;author=I.%20Buccimazza&amp;volume=258-259&amp;publication_year=2021&amp;pages=1-6&amp;pmid=34218100&amp;doi=10.1016/j.cancergen.2021.06.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<cite>
Conley C. C., Ketcher D., Reblin M., Kasting M. L., Cragun D., Kim J., et al.  (2020). The Big Reveal: Family Disclosure Patterns of BRCA Genetic Test Results Among Young Black Women with Invasive Breast Cancer. Jrnl of Gene Coun
29, 410–422. 10.1002/jgc4.1196
</cite> [<a href="https://doi.org/10.1002/jgc4.1196" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7343233/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31912597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jrnl%20of%20Gene%20Coun&amp;title=The%20Big%20Reveal:%20Family%20Disclosure%20Patterns%20of%20BRCA%20Genetic%20Test%20Results%20Among%20Young%20Black%20Women%20with%20Invasive%20Breast%20Cancer&amp;author=C.%20C.%20Conley&amp;author=D.%20Ketcher&amp;author=M.%20Reblin&amp;author=M.%20L.%20Kasting&amp;author=D.%20Cragun&amp;volume=29&amp;publication_year=2020&amp;pages=410-422&amp;pmid=31912597&amp;doi=10.1002/jgc4.1196&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<cite>
El Ansari F. Z., Jouali F., Marchoudi N., Bennani M. M., Ghailani N. N., Barakat A., et al.  (2020). Screening of <em>BRCA1/2</em> Genes Mutations and Copy Number Variations in Patients with High Risk for Hereditary Breast and Ovarian Cancer Syndrome (HBOC). BMC Cancer
20, 747. 10.1186/s12885-020-07250-0
</cite> [<a href="https://doi.org/10.1186/s12885-020-07250-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7418307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32778078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Screening%20of%20BRCA1/2%20Genes%20Mutations%20and%20Copy%20Number%20Variations%20in%20Patients%20with%20High%20Risk%20for%20Hereditary%20Breast%20and%20Ovarian%20Cancer%20Syndrome%20(HBOC)&amp;author=F.%20Z.%20El%20Ansari&amp;author=F.%20Jouali&amp;author=N.%20Marchoudi&amp;author=M.%20M.%20Bennani&amp;author=N.%20N.%20Ghailani&amp;volume=20&amp;publication_year=2020&amp;pages=747&amp;pmid=32778078&amp;doi=10.1186/s12885-020-07250-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<cite>
El Khachibi M., Diakite B., Hamzi K., Badou A., Senhaji M. A., Bakhchane A., et al.  (2015). Screening of Exon 11 of <em>BRCA1</em> Gene Using the High Resolution Melting Approach for Diagnosis in Moroccan Breast Cancer Patients. BMC Cancer
15, 81. 10.1186/s12885-015-1040-4
</cite> [<a href="https://doi.org/10.1186/s12885-015-1040-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4351675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25885115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Screening%20of%20Exon%2011%20of%20BRCA1%20Gene%20Using%20the%20High%20Resolution%20Melting%20Approach%20for%20Diagnosis%20in%20Moroccan%20Breast%20Cancer%20Patients&amp;author=M.%20El%20Khachibi&amp;author=B.%20Diakite&amp;author=K.%20Hamzi&amp;author=A.%20Badou&amp;author=M.%20A.%20Senhaji&amp;volume=15&amp;publication_year=2015&amp;pages=81&amp;pmid=25885115&amp;doi=10.1186/s12885-015-1040-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<cite>
Elias K. M., Guo J., Bast R. C., Jr (2018). Early Detection of Ovarian Cancer. Hematology/Oncology Clin. North America
32, 903–914. 10.1016/j.hoc.2018.07.003
</cite> [<a href="https://doi.org/10.1016/j.hoc.2018.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6376972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30390764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hematology/Oncology%20Clin.%20North%20America&amp;title=Early%20Detection%20of%20Ovarian%20Cancer&amp;author=K.%20M.%20Elias&amp;author=J.%20Guo&amp;author=R.%20C.%20Bast&amp;volume=32&amp;publication_year=2018&amp;pages=903-914&amp;pmid=30390764&amp;doi=10.1016/j.hoc.2018.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<cite>
Elnour A. M., Elderdery A. Y., Mills J., Mohammed B. A., ElbietAbdelaal D., Mohamed A. O. (2012). BRCA 1 and 2 Mutations in Sudanese Secondary School Girls with Known Breast Cancer in Their Families. Ijhs
6 (1), 63–71. 10.12816/0005974
</cite> [<a href="https://doi.org/10.12816/0005974" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3523784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23267305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ijhs&amp;title=BRCA%201%20and%202%20Mutations%20in%20Sudanese%20Secondary%20School%20Girls%20with%20Known%20Breast%20Cancer%20in%20Their%20Families&amp;author=A.%20M.%20Elnour&amp;author=A.%20Y.%20Elderdery&amp;author=J.%20Mills&amp;author=B.%20A.%20Mohammed&amp;author=D.%20ElbietAbdelaal&amp;volume=6&amp;issue=1&amp;publication_year=2012&amp;pages=63-71&amp;pmid=23267305&amp;doi=10.12816/0005974&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<cite>
Fourati A., Louchez M.-M., Fournier J., Gamoudi A., Rahal K., El May M.-V., et al.  (2014). Screening for Common Mutations in <em>BRCA1</em> and <em>BRCA2</em> Genes: Interest in Genetic Testing of Tunisian Families with Breast And/or Ovarian Cancer. Bull. du Cancer
101, E36–E40. 10.1684/bdc.2014.2049
</cite> [<a href="https://doi.org/10.1684/bdc.2014.2049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25418591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bull.%20du%20Cancer&amp;title=Screening%20for%20Common%20Mutations%20in%20BRCA1%20and%20BRCA2%20Genes:%20Interest%20in%20Genetic%20Testing%20of%20Tunisian%20Families%20with%20Breast%20And/or%20Ovarian%20Cancer&amp;author=A.%20Fourati&amp;author=M.-M.%20Louchez&amp;author=J.%20Fournier&amp;author=A.%20Gamoudi&amp;author=K.%20Rahal&amp;volume=101&amp;publication_year=2014&amp;pages=E36-E40&amp;pmid=25418591&amp;doi=10.1684/bdc.2014.2049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<cite>
Francies F. Z., WainsteinDe Leeneer T., De Leeneer K., Cairns A., Murdoch M., Nietz S., et al.  (2015). BRCA1, BRCA2 and PALB2 Mutations and CHEK2 c.1100delC in Different South African Ethnic Groups Diagnosed with Premenopausal And/or Triple Negative Breast Cancer. BMC Cancer
15, 912–921. 10.1186/s12885-015-1913-6
</cite> [<a href="https://doi.org/10.1186/s12885-015-1913-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4647511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26577449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=BRCA1,%20BRCA2%20and%20PALB2%20Mutations%20and%20CHEK2%20c.1100delC%20in%20Different%20South%20African%20Ethnic%20Groups%20Diagnosed%20with%20Premenopausal%20And/or%20Triple%20Negative%20Breast%20Cancer&amp;author=F.%20Z.%20Francies&amp;author=T.%20WainsteinDe%20Leeneer&amp;author=K.%20De%20Leeneer&amp;author=A.%20Cairns&amp;author=M.%20Murdoch&amp;volume=15&amp;publication_year=2015&amp;pages=912-921&amp;pmid=26577449&amp;doi=10.1186/s12885-015-1913-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<cite>
Gomaa Mogahed S. H., Hamed Y. S., Ibrahim Moursy Y. E., Mahomoud Saied M. H. (2020). Analysis of Heterozygous <em>BRCA1</em> 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique. Asian Pac. J. Cancer Prev.
21, 431–438. 10.31557/APJCP.2020.21.2.431
</cite> [<a href="https://doi.org/10.31557/APJCP.2020.21.2.431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7332123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32102521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pac.%20J.%20Cancer%20Prev.&amp;title=Analysis%20of%20Heterozygous%20BRCA1%205382ins%20Founder%20Mutation%20in%20a%20Cohort%20of%20Egyptian%20Breast%20Cancer%20Female%20Patients%20Using%20Pyrosequencing%20Technique&amp;author=S.%20H.%20Gomaa%20Mogahed&amp;author=Y.%20S.%20Hamed&amp;author=Y.%20E.%20Ibrahim%20Moursy&amp;author=M.%20H.%20Mahomoud%20Saied&amp;volume=21&amp;publication_year=2020&amp;pages=431-438&amp;pmid=32102521&amp;doi=10.31557/APJCP.2020.21.2.431&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<cite>
Hadiji-Abbes N., Trifa F., Choura M., Khabir A., Sellami-Boudawara T., Frikha M., et al.  (2015). A Novel BRCA2 in Frame Deletion in a Tunisian Woman with Early Onset Sporadic Breast Cancer. Pathologie Biologie
63, 185–189. 10.1016/j.patbio.2015.07.009
</cite> [<a href="https://doi.org/10.1016/j.patbio.2015.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26320393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathologie%20Biologie&amp;title=A%20Novel%20BRCA2%20in%20Frame%20Deletion%20in%20a%20Tunisian%20Woman%20with%20Early%20Onset%20Sporadic%20Breast%20Cancer&amp;author=N.%20Hadiji-Abbes&amp;author=F.%20Trifa&amp;author=M.%20Choura&amp;author=A.%20Khabir&amp;author=T.%20Sellami-Boudawara&amp;volume=63&amp;publication_year=2015&amp;pages=185-189&amp;pmid=26320393&amp;doi=10.1016/j.patbio.2015.07.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<cite>
Haga S. B., Barry W. T., Mills R., Ginsburg G. S., Svetkey L., Sullivan J., et al.  (2013). Public Knowledge of and Attitudes toward Genetics and Genetic Testing. Genet. Test. Mol. Biomarkers
17, 327–335. 10.1089/gtmb.2012.0350
</cite> [<a href="https://doi.org/10.1089/gtmb.2012.0350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3609633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23406207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Test.%20Mol.%20Biomarkers&amp;title=Public%20Knowledge%20of%20and%20Attitudes%20toward%20Genetics%20and%20Genetic%20Testing&amp;author=S.%20B.%20Haga&amp;author=W.%20T.%20Barry&amp;author=R.%20Mills&amp;author=G.%20S.%20Ginsburg&amp;author=L.%20Svetkey&amp;volume=17&amp;publication_year=2013&amp;pages=327-335&amp;pmid=23406207&amp;doi=10.1089/gtmb.2012.0350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<cite>
Hall D., Wijsman E. M., Roos J. L., Gogos J. A., Karayiorgou M. (2002). Extended Intermarker Linkage Disequilibrium in the Afrikaners. Genome Res.
12, 956–961. 10.1101/gr.136202
</cite> [<a href="https://doi.org/10.1101/gr.136202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC548332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12045148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res.&amp;title=Extended%20Intermarker%20Linkage%20Disequilibrium%20in%20the%20Afrikaners&amp;author=D.%20Hall&amp;author=E.%20M.%20Wijsman&amp;author=J.%20L.%20Roos&amp;author=J.%20A.%20Gogos&amp;author=M.%20Karayiorgou&amp;volume=12&amp;publication_year=2002&amp;pages=956-961&amp;pmid=12045148&amp;doi=10.1101/gr.136202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<cite>
Hamdi Y., Mighri N., Boujemaa M., Mejri N., Nasr S. N., Rekaya M. B., et al.  (2021). Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of <em>BRCA</em> Related Cancers. Res. Sq. 10.3389/fonc.2021.674965) </cite> [<a href="https://doi.org/10.3389/fonc.2021.674965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8417726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34490083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res.%20Sq&amp;title=Identification%20of%20Eleven%20Novel%20BRCA%20Mutations%20in%20Tunisia:%20Impact%20on%20the%20Clinical%20Management%20of%20BRCA%20Related%20Cancers&amp;author=Y.%20Hamdi&amp;author=N.%20Mighri&amp;author=M.%20Boujemaa&amp;author=N.%20Mejri&amp;author=S.%20N.%20Nasr&amp;publication_year=2021&amp;pmid=34490083&amp;doi=10.3389/fonc.2021.674965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<cite>
Henneman L., Vermeulen E., van El C. G., Claassen L., Timmermans D. R. M., Cornel M. C. (2013). Public Attitudes towards Genetic Testing Revisited: Comparing Opinions between 2002 and 2010. Eur. J. Hum. Genet.
21, 793–799. 10.1038/ejhg.2012.271
</cite> [<a href="https://doi.org/10.1038/ejhg.2012.271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3722681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23249955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=Public%20Attitudes%20towards%20Genetic%20Testing%20Revisited:%20Comparing%20Opinions%20between%202002%20and%202010&amp;author=L.%20Henneman&amp;author=E.%20Vermeulen&amp;author=C.%20G.%20van%20El&amp;author=L.%20Claassen&amp;author=D.%20R.%20M.%20Timmermans&amp;volume=21&amp;publication_year=2013&amp;pages=793-799&amp;pmid=23249955&amp;doi=10.1038/ejhg.2012.271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<cite>
Henouda S., Bensalem A., Reggad R., Serrar N., Rouabah L., 1 Pujo P. (2016). Contribution of <em>BRCA1</em> and <em>BRCA2</em> Germline Mutations to Early Algerian Breast Cancer. Dis. Markers. 10.1155/2016/7869095) </cite> [<a href="https://doi.org/10.1155/2016/7869095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4779828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26997744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis.%20Markers&amp;title=Contribution%20of%20BRCA1%20and%20BRCA2%20Germline%20Mutations%20to%20Early%20Algerian%20Breast%20Cancer&amp;author=S.%20Henouda&amp;author=A.%20Bensalem&amp;author=R.%20Reggad&amp;author=N.%20Serrar&amp;author=L.%20Rouabah&amp;publication_year=2016&amp;pmid=26997744&amp;doi=10.1155/2016/7869095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<cite>
Hollfelder N., Erasmus J. C., Hammaren R., Vicente M., Jakobsson M., Greeff J. M., et al.  (2020). Patterns of African and Asian Admixture in the Afrikaner Population of South Africa. BMC Biol.
18, 1–16. 10.1186/s12915-020-0746-1
</cite> [<a href="https://doi.org/10.1186/s12915-020-0746-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7038537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32089133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Biol.&amp;title=Patterns%20of%20African%20and%20Asian%20Admixture%20in%20the%20Afrikaner%20Population%20of%20South%20Africa&amp;author=N.%20Hollfelder&amp;author=J.%20C.%20Erasmus&amp;author=R.%20Hammaren&amp;author=M.%20Vicente&amp;author=M.%20Jakobsson&amp;volume=18&amp;publication_year=2020&amp;pages=1-16&amp;pmid=32089133&amp;doi=10.1186/s12915-020-0746-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<cite>
Isaacs S., Geduld-Ullah T., Benjeddou M. (2013). Reconstruction of Major Maternal and Paternal Lineages of the Cape Muslim Population. Genet. Mol. Biol.
36, 167–176. 10.1590/S1415-47572013005000019
</cite> [<a href="https://doi.org/10.1590/S1415-47572013005000019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3715281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23885197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Mol.%20Biol.&amp;title=Reconstruction%20of%20Major%20Maternal%20and%20Paternal%20Lineages%20of%20the%20Cape%20Muslim%20Population&amp;author=S.%20Isaacs&amp;author=T.%20Geduld-Ullah&amp;author=M.%20Benjeddou&amp;volume=36&amp;publication_year=2013&amp;pages=167-176&amp;pmid=23885197&amp;doi=10.1590/S1415-47572013005000019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<cite>
Joffe M., Ayeni O., Norris S. A., McCormack V. A., Ruff P., Das I., et al.  (2018). Barriers to Early Presentation of Breast Cancer Among Women in Soweto, South Africa. PLoS ONE
13, e0192071. 10.1371/journal.pone.0192071
</cite> [<a href="https://doi.org/10.1371/journal.pone.0192071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5796726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29394271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Barriers%20to%20Early%20Presentation%20of%20Breast%20Cancer%20Among%20Women%20in%20Soweto,%20South%20Africa&amp;author=M.%20Joffe&amp;author=O.%20Ayeni&amp;author=S.%20A.%20Norris&amp;author=V.%20A.%20McCormack&amp;author=P.%20Ruff&amp;volume=13&amp;publication_year=2018&amp;pages=e0192071&amp;pmid=29394271&amp;doi=10.1371/journal.pone.0192071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<cite>
Jouali F., Laarabi F.-Z., Marchoudi N., Ratbi I., Elalaoui S. C., Rhaissi H., et al.  (2016). First Application of Next-Generation Sequencing in Moroccan Breast/ovarian Cancer Families and Report of a Novel Frameshift Mutation of the <em>BRCA1</em> Gene. Oncol. Lett.
12, 1192–1196. 10.3892/ol.2016.4739
</cite> [<a href="https://doi.org/10.3892/ol.2016.4739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4950805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27446417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Lett.&amp;title=First%20Application%20of%20Next-Generation%20Sequencing%20in%20Moroccan%20Breast/ovarian%20Cancer%20Families%20and%20Report%20of%20a%20Novel%20Frameshift%20Mutation%20of%20the%20BRCA1%20Gene&amp;author=F.%20Jouali&amp;author=F.-Z.%20Laarabi&amp;author=N.%20Marchoudi&amp;author=I.%20Ratbi&amp;author=S.%20C.%20Elalaoui&amp;volume=12&amp;publication_year=2016&amp;pages=1192-1196&amp;pmid=27446417&amp;doi=10.3892/ol.2016.4739&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<cite>
Kan C., Zhang J. (2015). 
<em>BRCA1</em> Mutation: a Predictive Marker for Radiation Therapy?
Int. J. Radiat. Oncology*Biology*Physics
93, 281–293. 10.1016/j.ijrobp.2015.05.037
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2015.05.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4576355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26383678/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Radiat.%20Oncology*Biology*Physics&amp;title=BRCA1%20Mutation:%20a%20Predictive%20Marker%20for%20Radiation%20Therapy?&amp;author=C.%20Kan&amp;author=J.%20Zhang&amp;volume=93&amp;publication_year=2015&amp;pages=281-293&amp;pmid=26383678&amp;doi=10.1016/j.ijrobp.2015.05.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<cite>
Kopanos C., Tsiolkas V., Kouris A., Chapple C. E., Albarca Aguilera M., Meyer R., et al.  (2019). VarSome: the Human Genomic Variant Search Engine. Bioinformatics
35, 1978–1980. 10.1093/bioinformatics/bty897
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30376034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=VarSome:%20the%20Human%20Genomic%20Variant%20Search%20Engine&amp;author=C.%20Kopanos&amp;author=V.%20Tsiolkas&amp;author=A.%20Kouris&amp;author=C.%20E.%20Chapple&amp;author=M.%20Albarca%20Aguilera&amp;volume=35&amp;publication_year=2019&amp;pages=1978-1980&amp;pmid=30376034&amp;doi=10.1093/bioinformatics/bty897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<cite>
Kuchenbaecker K. B., Hopper J. L., Barnes D. R., Phillips K.-A., Mooij T. M., Roos-Blom M.-J., et al.  (2017). Risks of Breast, Ovarian, and Contralateral Breast Cancer for <em>BRCA1</em> and <em>BRCA2</em> Mutation Carriers. JAMA
317, 2402–2416. 10.1001/jama.2017.7112
</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Risks%20of%20Breast,%20Ovarian,%20and%20Contralateral%20Breast%20Cancer%20for%20BRCA1%20and%20BRCA2%20Mutation%20Carriers&amp;author=K.%20B.%20Kuchenbaecker&amp;author=J.%20L.%20Hopper&amp;author=D.%20R.%20Barnes&amp;author=K.-A.%20Phillips&amp;author=T.%20M.%20Mooij&amp;volume=317&amp;publication_year=2017&amp;pages=2402-2416&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<cite>
Laarabi F.-Z., Ratbi I., Elalaoui S. C., Mezzouar L., Doubaj Y., Bouguenouch L., et al.  (2017). High Frequency of the Recurrent c.1310_1313delAAGA <em>BRCA2</em> Mutation in the North-East of Morocco and Implication for Hereditary Breast-Ovarian Cancer Prevention and Control. BMC Res. Notes
10, 188. 10.1186/s13104-017-2511-2
</cite> [<a href="https://doi.org/10.1186/s13104-017-2511-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5457611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28577564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Res.%20Notes&amp;title=High%20Frequency%20of%20the%20Recurrent%20c.1310_1313delAAGA%20BRCA2%20Mutation%20in%20the%20North-East%20of%20Morocco%20and%20Implication%20for%20Hereditary%20Breast-Ovarian%20Cancer%20Prevention%20and%20Control&amp;author=F.-Z.%20Laarabi&amp;author=I.%20Ratbi&amp;author=S.%20C.%20Elalaoui&amp;author=L.%20Mezzouar&amp;author=Y.%20Doubaj&amp;volume=10&amp;publication_year=2017&amp;pages=188&amp;pmid=28577564&amp;doi=10.1186/s13104-017-2511-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<cite>
Laraqui A., Uhrhammer N., Lahlou-Amine I., Rhaffouli H. E., Baghdadi J. E., Dehayni M., et al.  (2013). Mutation Screening of the <em>BRCA1</em> Gene in Early Onset and Familial Breast/Ovarian Cancer in Moroccan Population. Int. J. Med. Sci.
10, 60–67. 10.7150/ijms.5014
</cite> [<a href="https://doi.org/10.7150/ijms.5014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3534878/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23289006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Med.%20Sci.&amp;title=Mutation%20Screening%20of%20the%20BRCA1%20Gene%20in%20Early%20Onset%20and%20Familial%20Breast/Ovarian%20Cancer%20in%20Moroccan%20Population&amp;author=A.%20Laraqui&amp;author=N.%20Uhrhammer&amp;author=I.%20Lahlou-Amine&amp;author=H.%20E.%20Rhaffouli&amp;author=J.%20E.%20Baghdadi&amp;volume=10&amp;publication_year=2013&amp;pages=60-67&amp;pmid=23289006&amp;doi=10.7150/ijms.5014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<cite>
Larsen M. J., Thomassen M., Gerdes A-M., Kruse T. A. (2014). Breast Cancer: Basic Clin Res.
10.4137/bcbcr.s18715
Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics) </cite> [<a href="https://doi.org/10.4137/bcbcr.s18715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4213954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25368521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Breast%20Cancer:%20Basic%20Clin%20Res.&amp;author=M.%20J.%20Larsen&amp;author=M.%20Thomassen&amp;author=A-M.%20Gerdes&amp;author=T.%20A.%20Kruse&amp;publication_year=2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<cite>
Loizzi V., Ranieri G., Laforgia M., Gadaleta C., Gargano G., Kardhashi A., et al.  (2020). PARP Inhibitors and Epithelial Ovarian Cancer: Molecular Mechanisms, Clinical Development and Future Prospective (Review). Oncol. Lett.
20, 1. 10.3892/ol.2020.11951
</cite> [<a href="https://doi.org/10.3892/ol.2020.11951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7439101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32831909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Lett.&amp;title=PARP%20Inhibitors%20and%20Epithelial%20Ovarian%20Cancer:%20Molecular%20Mechanisms,%20Clinical%20Development%20and%20Future%20Prospective%20(Review)&amp;author=V.%20Loizzi&amp;author=G.%20Ranieri&amp;author=M.%20Laforgia&amp;author=C.%20Gadaleta&amp;author=G.%20Gargano&amp;volume=20&amp;publication_year=2020&amp;pages=1&amp;pmid=32831909&amp;doi=10.3892/ol.2020.11951&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<cite>
Mahfoudh W., Bouaouina N., Ahmed S. B., Gabbouj S., Shan J., Mathew R., et al.  (2012). Hereditary Breast Cancer in Middle Eastern and North African (MENA) Populations: Identification of Novel, Recurrent and Founder <em>BRCA1</em> Mutations in the Tunisian Population. Mol. Biol. Rep.
39, 1037–1046. 10.1007/s11033-011-0829-8
</cite> [<a href="https://doi.org/10.1007/s11033-011-0829-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3249560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21603858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Biol.%20Rep.&amp;title=Hereditary%20Breast%20Cancer%20in%20Middle%20Eastern%20and%20North%20African%20(MENA)%20Populations:%20Identification%20of%20Novel,%20Recurrent%20and%20Founder%20BRCA1%20Mutations%20in%20the%20Tunisian%20Population&amp;author=W.%20Mahfoudh&amp;author=N.%20Bouaouina&amp;author=S.%20B.%20Ahmed&amp;author=S.%20Gabbouj&amp;author=J.%20Shan&amp;volume=39&amp;publication_year=2012&amp;pages=1037-1046&amp;pmid=21603858&amp;doi=10.1007/s11033-011-0829-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<cite>
Mampunye L., van der Merwe N. C., Grant K. A., Peeters A. V., Torrorey-Sawe R., French D. J., et al.  (2021). Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics. Front. Oncol.
11, 619817. 10.3389/fonc.2021.619817
</cite> [<a href="https://doi.org/10.3389/fonc.2021.619817" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8513538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34660253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Pioneering%20BRCA1/2%20Point-Of-Care%20Testing%20for%20Integration%20of%20Germline%20and%20Tumor%20Genetics%20in%20Breast%20Cancer%20Risk%20Management:%20A%20Vision%20for%20the%20Future%20of%20Translational%20Pharmacogenomics&amp;author=L.%20Mampunye&amp;author=N.%20C.%20van%20der%20Merwe&amp;author=K.%20A.%20Grant&amp;author=A.%20V.%20Peeters&amp;author=R.%20Torrorey-Sawe&amp;volume=11&amp;publication_year=2021&amp;pages=619817&amp;pmid=34660253&amp;doi=10.3389/fonc.2021.619817&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<cite>
Mansouri M., Derkaoui T., Bakkach J., Loudiyi A., Ghailani Nourouti N., Barakat A., et al.  (2020). Screening of BRCA1 and BRCA2 Germline Mutations in Unselected Triple‐negative Breast Cancer Patients: A Series from north of Morocco. Precision Med. Sci.
9, 43–48. 10.1002/prm2.12009
</cite> [<a href="https://doi.org/10.1002/prm2.12009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Precision%20Med.%20Sci.&amp;title=Screening%20of%20BRCA1%20and%20BRCA2%20Germline%20Mutations%20in%20Unselected%20Triple%E2%80%90negative%20Breast%20Cancer%20Patients:%20A%20Series%20from%20north%20of%20Morocco&amp;author=M.%20Mansouri&amp;author=T.%20Derkaoui&amp;author=J.%20Bakkach&amp;author=A.%20Loudiyi&amp;author=N.%20Ghailani%20Nourouti&amp;volume=9&amp;publication_year=2020&amp;pages=43-48&amp;doi=10.1002/prm2.12009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<cite>
McCarthy A. M., Armstrong K. (2014). The Role of Testing forBRCA1andBRCA2Mutations in Cancer Prevention. JAMA Intern. Med.
174 (7), 1023–1024. 10.1001/jamainternmed.2014.1322
</cite> [<a href="https://doi.org/10.1001/jamainternmed.2014.1322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4169670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24841841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern.%20Med.&amp;title=The%20Role%20of%20Testing%20forBRCA1andBRCA2Mutations%20in%20Cancer%20Prevention&amp;author=A.%20M.%20McCarthy&amp;author=K.%20Armstrong&amp;volume=174&amp;issue=7&amp;publication_year=2014&amp;pages=1023-1024&amp;pmid=24841841&amp;doi=10.1001/jamainternmed.2014.1322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<cite>
Mehemmai C., Cherbal F., Hamdi Y., Guedioura A., Benbrahim W., Bakour R., et al.  (2020). 
<em>BRCA1</em> and <em>BRCA2</em> Germline Mutation Analysis in Hereditary Breast/ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report. Pathol. Oncol. Res.
26, 715–726. 10.1007/s12253-019-00586-4
</cite> [<a href="https://doi.org/10.1007/s12253-019-00586-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30715675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol.%20Oncol.%20Res.&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutation%20Analysis%20in%20Hereditary%20Breast/ovarian%20Cancer%20Families%20from%20the%20Aures%20Region%20(Eastern%20Algeria):%20First%20Report&amp;author=C.%20Mehemmai&amp;author=F.%20Cherbal&amp;author=Y.%20Hamdi&amp;author=A.%20Guedioura&amp;author=W.%20Benbrahim&amp;volume=26&amp;publication_year=2020&amp;pages=715-726&amp;pmid=30715675&amp;doi=10.1007/s12253-019-00586-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<cite>
Mesthrie R. (2006). World Englishes and the Multilingual History of English. World Englishes
25, 381–390. 10.1111/j.1467-971x.2006.00477.x
</cite> [<a href="https://doi.org/10.1111/j.1467-971x.2006.00477.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Englishes&amp;title=World%20Englishes%20and%20the%20Multilingual%20History%20of%20English&amp;author=R.%20Mesthrie&amp;volume=25&amp;publication_year=2006&amp;pages=381-390&amp;doi=10.1111/j.1467-971x.2006.00477.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<cite>
Mestiri S., Monastiri K., Bouaouina N., Presnea N., Bignon Y. J., Khairi H., et al.  (2000). Mutational Analysis of Breast/ovarian Cancer Hereditary Predisposition Gene <em>BRCA1</em> in Tunisian Women, 77. Arch Institut Pasteur Tunis, 11–15. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/14658222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Mutational%20Analysis%20of%20Breast/ovarian%20Cancer%20Hereditary%20Predisposition%20Gene%20BRCA1%20in%20Tunisian%20Women&amp;author=S.%20Mestiri&amp;author=K.%20Monastiri&amp;author=N.%20Bouaouina&amp;author=N.%20Presnea&amp;author=Y.%20J.%20Bignon&amp;publication_year=2000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<cite>
Mighri N., Hamdi Y., Boujemaa M., Othman H., Nasr S. B., El Benna H., et al.  (2020). Identification of Novel <em>BRCA1</em> and <em>RAD50</em> Mutations Associated with Breast Cancer Predisposition in Tunisian Patients. Front. Genet.
10.3389/fgene.2020.552971
</cite> [<a href="https://doi.org/10.3389/fgene.2020.552971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7677579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33240314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Identification%20of%20Novel%20BRCA1%20and%20RAD50%20Mutations%20Associated%20with%20Breast%20Cancer%20Predisposition%20in%20Tunisian%20Patients&amp;author=N.%20Mighri&amp;author=Y.%20Hamdi&amp;author=M.%20Boujemaa&amp;author=H.%20Othman&amp;author=S.%20B.%20Nasr&amp;publication_year=2020&amp;pmid=33240314&amp;doi=10.3389/fgene.2020.552971&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<cite>
Moeti P. J. (2016). Molecular Screening for the Presence of Large Deletions or Duplications in <em>BRCA</em> Using Multiplex Ligation-dependent Probe Amplification in South Africa. M.Med.Sc. Dissertation.. Bloemfontein: University of the Free State. Available at: <a href="https://scholar.ufs.ac.za/handle/11660/5392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scholar.ufs.ac.za/handle/11660/5392</a> (Accessed September 14, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Molecular%20Screening%20for%20the%20Presence%20of%20Large%20Deletions%20or%20Duplications%20in%20BRCA%20Using%20Multiplex%20Ligation-dependent%20Probe%20Amplification%20in%20South%20Africa.%20M.Med.Sc.%20Dissertation.&amp;author=P.%20J.%20Moeti&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<cite>
Msolly A., Asma K. (2015). 
<em>BRCA1</em> and <em>BRCA2</em> Mutations Are They Related to Breast Cancer in a Sample of Tunisian Population?
Ctoij
1. 10.19080/CTOIJ.2015.01.555551
</cite> [<a href="https://doi.org/10.19080/CTOIJ.2015.01.555551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ctoij&amp;title=BRCA1%20and%20BRCA2%20Mutations%20Are%20They%20Related%20to%20Breast%20Cancer%20in%20a%20Sample%20of%20Tunisian%20Population?&amp;author=A.%20Msolly&amp;author=K.%20Asma&amp;volume=1&amp;publication_year=2015&amp;doi=10.19080/CTOIJ.2015.01.555551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<cite>
Mukem S., Meng Q., Sriplung H., Tangcharoensathien V. (2016). Low Coverage and Disparities of Breast and Cervical Cancer Screening in Thai Women: Analysis of National Representative Household Surveys. Asian Pac. J. Cancer Prev.
16, 8541–8551. 10.7314/apjcp.2015.16.18.8541
</cite> [<a href="https://doi.org/10.7314/apjcp.2015.16.18.8541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26745114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pac.%20J.%20Cancer%20Prev.&amp;title=Low%20Coverage%20and%20Disparities%20of%20Breast%20and%20Cervical%20Cancer%20Screening%20in%20Thai%20Women:%20Analysis%20of%20National%20Representative%20Household%20Surveys&amp;author=S.%20Mukem&amp;author=Q.%20Meng&amp;author=H.%20Sriplung&amp;author=V.%20Tangcharoensathien&amp;volume=16&amp;publication_year=2016&amp;pages=8541-8551&amp;pmid=26745114&amp;doi=10.7314/apjcp.2015.16.18.8541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<cite>
National Department of Health of the Republic of South Africa (2018). Clinical Guidelines for Breast Cancer Control and Management. Pretoria, South Africa: Department of Health, 1–123. Available at: <a href="https://cansa.org.za/files/2019/08/DOH-Breast-Cancer-Guidelines-Final.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cansa.org.za/files/2019/08/DOH-Breast-Cancer-Guidelines-Final.pdf</a>
. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Clinical%20Guidelines%20for%20Breast%20Cancer%20Control%20and%20Management&amp;author=%20National%20Department%20of%20Health%20of%20the%20Republic%20of%20South%20Africa&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<cite>
Ndiaye R., Diop J. P. D., Bourdon-Huguenin V., Dem A., Diouf D., Dieng M. M., et al.  (2020). Evidence for an Ancient <em>BRCA1</em> Pathogenic Variant in Inherited Breast Cancer Patients from Senegal. Npj Genom. Med.
5, 8. 10.1038/s41525-020-0114-7
</cite> [<a href="https://doi.org/10.1038/s41525-020-0114-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6994613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32025337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Npj%20Genom.%20Med.&amp;title=Evidence%20for%20an%20Ancient%20BRCA1%20Pathogenic%20Variant%20in%20Inherited%20Breast%20Cancer%20Patients%20from%20Senegal&amp;author=R.%20Ndiaye&amp;author=J.%20P.%20D.%20Diop&amp;author=V.%20Bourdon-Huguenin&amp;author=A.%20Dem&amp;author=D.%20Diouf&amp;volume=5&amp;publication_year=2020&amp;pages=8&amp;pmid=32025337&amp;doi=10.1038/s41525-020-0114-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<cite>
Oosthuizen J. (2016). Molecular Screening of Coloured South African Breast Cancer Patients for the Presence of <em>BRCA</em> Mutations Using High Resolution Melting analysis. MMedSc Dissertation.
Bloemfontein: University of the Free State. Available at: <a href="https://scholar.ufs.ac.za/handle/11660/6426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scholar.ufs.ac.za/handle/11660/6426</a> (Accessed September 13, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Molecular%20Screening%20of%20Coloured%20South%20African%20Breast%20Cancer%20Patients%20for%20the%20Presence%20of%20BRCA%20Mutations%20Using%20High%20Resolution%20Melting%20analysis.%20MMedSc%20Dissertation.&amp;author=J.%20Oosthuizen&amp;publication_year=2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<cite>
Oosthuizen J., Kotze M. J., van der Merwe N., Myburgh E. J., Bester P., van der Merwe N. C. (2021). Globally Rare <em>BRCA2</em> Variants with Founder Haplotypes in the South African Population: Implications for point-of-care Testing Based on a Single-Institution <em>BRCA1/2</em> Next-Generation Sequencing Study. Front. Oncol.
10. 10.3389/fonc.2020.619469
</cite> [<a href="https://doi.org/10.3389/fonc.2020.619469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7908826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33643918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Globally%20Rare%20BRCA2%20Variants%20with%20Founder%20Haplotypes%20in%20the%20South%20African%20Population:%20Implications%20for%20point-of-care%20Testing%20Based%20on%20a%20Single-Institution%20BRCA1/2%20Next-Generation%20Sequencing%20Study&amp;author=J.%20Oosthuizen&amp;author=M.%20J.%20Kotze&amp;author=N.%20van%20der%20Merwe&amp;author=E.%20J.%20Myburgh&amp;author=P.%20Bester&amp;volume=10&amp;publication_year=2021&amp;pmid=33643918&amp;doi=10.3389/fonc.2020.619469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<cite>
Opolade O. I., Gao Q., Adebamowo C. A., Fackenthal J., Das S., Sveen L., et al.  (2000). Protein Truncating <em>BRCA1</em> and <em>BRCA2</em> Mutations in African Women with Pre-menopausal Breast Cancer. Hum. Genet.
107, 192–194. 10.1007/s004390000342
</cite> [<a href="https://doi.org/10.1007/s004390000342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11030418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genet.&amp;title=Protein%20Truncating%20BRCA1%20and%20BRCA2%20Mutations%20in%20African%20Women%20with%20Pre-menopausal%20Breast%20Cancer&amp;author=O.%20I.%20Opolade&amp;author=Q.%20Gao&amp;author=C.%20A.%20Adebamowo&amp;author=J.%20Fackenthal&amp;author=S.%20Das&amp;volume=107&amp;publication_year=2000&amp;pages=192-194&amp;pmid=11030418&amp;doi=10.1007/s004390000342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<cite>
Peltzer K., Phaswana-Mafuya N. (2014). Breast and Cervical Cancer Screening and Associated Factors Among Older Adult Women in South Africa. Asian Pac. J. Cancer Prev.
15, 2473–2476. 10.7314/apjcp.2014.15.6.2473
</cite> [<a href="https://doi.org/10.7314/apjcp.2014.15.6.2473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24761849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pac.%20J.%20Cancer%20Prev.&amp;title=Breast%20and%20Cervical%20Cancer%20Screening%20and%20Associated%20Factors%20Among%20Older%20Adult%20Women%20in%20South%20Africa&amp;author=K.%20Peltzer&amp;author=N.%20Phaswana-Mafuya&amp;volume=15&amp;publication_year=2014&amp;pages=2473-2476&amp;pmid=24761849&amp;doi=10.7314/apjcp.2014.15.6.2473&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64">
<cite>
Peter N. (2014). Screening of Young And/or Familial African Breast Cancer Patients for the Presence of <em>BRCA</em> Mutations. M.Med.Sc. Dissertation. Bloemfontein: University of the Free State. Available at: <a href="https://scholar.ufs.ac.za/handle/11660/1613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scholar.ufs.ac.za/handle/11660/1613</a> (Accessed September 14, 2021)
</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Screening%20of%20Young%20And/or%20Familial%20African%20Breast%20Cancer%20Patients%20for%20the%20Presence%20of%20BRCA%20Mutations.%20M.Med.Sc.%20Dissertation&amp;author=N.%20Peter&amp;publication_year=2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65">
<cite>
Phaswana-Mafuya N., Peltzer K. (2018). Breast and Cervical Cancer Screening Prevalence and Associated Factors Among Women in the South African General Population. Asian Pac. J. Cancer Prev.
19, 1465–1470. 10.22034/apjcp.2018.19.6.1465
</cite> [<a href="https://doi.org/10.22034/apjcp.2018.19.6.1465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6103566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29936716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pac.%20J.%20Cancer%20Prev.&amp;title=Breast%20and%20Cervical%20Cancer%20Screening%20Prevalence%20and%20Associated%20Factors%20Among%20Women%20in%20the%20South%20African%20General%20Population&amp;author=N.%20Phaswana-Mafuya&amp;author=K.%20Peltzer&amp;volume=19&amp;publication_year=2018&amp;pages=1465-1470&amp;pmid=29936716&amp;doi=10.22034/apjcp.2018.19.6.1465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66">
<cite>
Reeves M. D., Yawitch T. M., Van der Merwe N. C., Van den Berg H. J., Dreyer G., Van Rensburg E. J. (2004). 
<em>BRCA1</em> Mutations in South African Breast And/or Ovarian Cancer Families: Evidence of a Novel Founder Mutation in Afrikaner Families. Int. J. Cancer
110, 677–682. 10.1002/ijc.20186
</cite> [<a href="https://doi.org/10.1002/ijc.20186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15146556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=BRCA1%20Mutations%20in%20South%20African%20Breast%20And/or%20Ovarian%20Cancer%20Families:%20Evidence%20of%20a%20Novel%20Founder%20Mutation%20in%20Afrikaner%20Families&amp;author=M.%20D.%20Reeves&amp;author=T.%20M.%20Yawitch&amp;author=N.%20C.%20Van%20der%20Merwe&amp;author=H.%20J.%20Van%20den%20Berg&amp;author=G.%20Dreyer&amp;volume=110&amp;publication_year=2004&amp;pages=677-682&amp;pmid=15146556&amp;doi=10.1002/ijc.20186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67">
<cite>
Riahi A., Ghourabi M. e., Fourati A., Chaabouni-Bouhamed H. (2016). Family History Predictors of BRCA1/BRCA2 Mutation Status Among Tunisian Breast/ovarian Cancer Families. Breast Cancer
24, 238–244. 10.1007/s12282-016-0693-4
</cite> [<a href="https://doi.org/10.1007/s12282-016-0693-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27025497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Family%20History%20Predictors%20of%20BRCA1/BRCA2%20Mutation%20Status%20Among%20Tunisian%20Breast/ovarian%20Cancer%20Families&amp;author=A.%20Riahi&amp;author=M.%20e.%20Ghourabi&amp;author=A.%20Fourati&amp;author=H.%20Chaabouni-Bouhamed&amp;volume=24&amp;publication_year=2016&amp;pages=238-244&amp;pmid=27025497&amp;doi=10.1007/s12282-016-0693-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68">
<cite>
Riahi A., Kharrat M., Ghourabi M. E., Khomsi F., Gamoudi A., Lariani I., et al.  (2014). Mutation Spectrum and Prevalence ofBRCA1 andBRCA2 Genes in Patients with Familial and Early-Onset Breast/ovarian Cancer from Tunisia. Clin. Genet.
87, 155–160. 10.1111/cge.12337
</cite> [<a href="https://doi.org/10.1111/cge.12337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24372583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Mutation%20Spectrum%20and%20Prevalence%20ofBRCA1%20andBRCA2%20Genes%20in%20Patients%20with%20Familial%20and%20Early-Onset%20Breast/ovarian%20Cancer%20from%20Tunisia&amp;author=A.%20Riahi&amp;author=M.%20Kharrat&amp;author=M.%20E.%20Ghourabi&amp;author=F.%20Khomsi&amp;author=A.%20Gamoudi&amp;volume=87&amp;publication_year=2014&amp;pages=155-160&amp;pmid=24372583&amp;doi=10.1111/cge.12337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69">
<cite>
Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., et al.  (2015). Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med.
17, 405–424. 10.1038/gim.2015.30
</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Standards%20and%20Guidelines%20for%20the%20Interpretation%20of%20Sequence%20Variants:%20a%20Joint%20Consensus%20Recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;author=D.%20Bick&amp;author=S.%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70">
<cite>
Salmi F., Maachi F., Tazzite A., Aboutaib R., Fekkak J., Azeddoug H., et al.  (2021). Next-generation Sequencing of <em>BRCA1</em> and <em>BRCA2</em> Genes in Moroccan Prostate Cancer Patients with Positive Family History. PLoS ONE
16, e0254101. 10.1371/journal.pone.0254101
</cite> [<a href="https://doi.org/10.1371/journal.pone.0254101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8270444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34242281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Next-generation%20Sequencing%20of%20BRCA1%20and%20BRCA2%20Genes%20in%20Moroccan%20Prostate%20Cancer%20Patients%20with%20Positive%20Family%20History&amp;author=F.%20Salmi&amp;author=F.%20Maachi&amp;author=A.%20Tazzite&amp;author=R.%20Aboutaib&amp;author=J.%20Fekkak&amp;volume=16&amp;publication_year=2021&amp;pages=e0254101&amp;pmid=34242281&amp;doi=10.1371/journal.pone.0254101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71">
<cite>
Schlebusch C. M., Dreyer G., Sluiter M. D., Yawitch T. M., van den Berg H. J., van Rensburg E. J. (2010). Cancer Prevalence in 129 Breast-Ovarian Cancer Families Tested for <em>BRCA1</em> and <em>BRCA2</em> Mutations. S Afr. Med. J.
100, 113–117. 10.7196/samj.3235
</cite> [<a href="https://doi.org/10.7196/samj.3235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20459916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr.%20Med.%20J.&amp;title=Cancer%20Prevalence%20in%20129%20Breast-Ovarian%20Cancer%20Families%20Tested%20for%20BRCA1%20and%20BRCA2%20Mutations&amp;author=C.%20M.%20Schlebusch&amp;author=G.%20Dreyer&amp;author=M.%20D.%20Sluiter&amp;author=T.%20M.%20Yawitch&amp;author=H.%20J.%20van%20den%20Berg&amp;volume=100&amp;publication_year=2010&amp;pages=113-117&amp;pmid=20459916&amp;doi=10.7196/samj.3235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72">
<cite>
Schoeman M., Apffelstaedt J. P., Baatjes K., Urban M. (2013). Implementation of a Breast Cancer Genetic Service in South Africa - Lessons Learned. S Afr. Med. J.
103, 529–533. 10.7196/SAMJ.6814
</cite> [<a href="https://doi.org/10.7196/SAMJ.6814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23885733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr.%20Med.%20J.&amp;title=Implementation%20of%20a%20Breast%20Cancer%20Genetic%20Service%20in%20South%20Africa%20-%20Lessons%20Learned&amp;author=M.%20Schoeman&amp;author=J.%20P.%20Apffelstaedt&amp;author=K.%20Baatjes&amp;author=M.%20Urban&amp;volume=103&amp;publication_year=2013&amp;pages=529-533&amp;pmid=23885733&amp;doi=10.7196/SAMJ.6814&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73">
<cite>
Seymour H. J., Wainstein T., Macaulay S. S., Haw T., Krause A. (2016). Breast Cancer in High-Risk Afrikaner Families: Is <em>BRCA</em> Founder Mutation Testing Sufficient?
S Afr. Med. J.
106, 264–267. 10.7196/SAMJ.2016.v106i3.10285
</cite> [<a href="https://doi.org/10.7196/SAMJ.2016.v106i3.10285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26915939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr.%20Med.%20J.&amp;title=Breast%20Cancer%20in%20High-Risk%20Afrikaner%20Families:%20Is%20BRCA%20Founder%20Mutation%20Testing%20Sufficient?&amp;author=H.%20J.%20Seymour&amp;author=T.%20Wainstein&amp;author=S.%20S.%20Macaulay&amp;author=T.%20Haw&amp;author=A.%20Krause&amp;volume=106&amp;publication_year=2016&amp;pages=264-267&amp;pmid=26915939&amp;doi=10.7196/SAMJ.2016.v106i3.10285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74">
<cite>
Sluiter M. D., Van Rensburg E. J. (2011). Large Genomic Rearrangements of the <em>BRCA1</em> and <em>BRCA2</em> Genes: Review of the Literature and Report of a Novel <em>BRCA1</em> Mutation. Breast Cancer Res. Treat.
125, 325–349. 10.1007/s10549-010-0817-z
</cite> [<a href="https://doi.org/10.1007/s10549-010-0817-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20232141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Large%20Genomic%20Rearrangements%20of%20the%20BRCA1%20and%20BRCA2%20Genes:%20Review%20of%20the%20Literature%20and%20Report%20of%20a%20Novel%20BRCA1%20Mutation&amp;author=M.%20D.%20Sluiter&amp;author=E.%20J.%20Van%20Rensburg&amp;volume=125&amp;publication_year=2011&amp;pages=325-349&amp;pmid=20232141&amp;doi=10.1007/s10549-010-0817-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75">
<cite>
Sözmen K., Unal B., Sakarya S., Dinc G., Yardim N., Keskinkilic B., et al.  (2016). Determinants of Breast and Cervical Cancer Screening Uptake Among Women in Turkey. Asia Pac. J. Public Health
28, 528–538. 10.1177/1010539516654541
</cite> [<a href="https://doi.org/10.1177/1010539516654541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27354286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asia%20Pac.%20J.%20Public%20Health&amp;title=Determinants%20of%20Breast%20and%20Cervical%20Cancer%20Screening%20Uptake%20Among%20Women%20in%20Turkey&amp;author=K.%20S%C3%B6zmen&amp;author=B.%20Unal&amp;author=S.%20Sakarya&amp;author=G.%20Dinc&amp;author=N.%20Yardim&amp;volume=28&amp;publication_year=2016&amp;pages=528-538&amp;pmid=27354286&amp;doi=10.1177/1010539516654541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76">
<cite>
Spurdle A. B., Jenkins T. (1996). The Origins of the Lemba "Black Jews" of Southern Africa: Evidence from p12F2 and Other Y-Chromosome Markers. Am. J. Hum. Genet.
59, 1126–1133. </cite> [<a href="/articles/PMC1914832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8900243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=The%20Origins%20of%20the%20Lemba%20%22Black%20Jews%22%20of%20Southern%20Africa:%20Evidence%20from%20p12F2%20and%20Other%20Y-Chromosome%20Markers&amp;author=A.%20B.%20Spurdle&amp;author=T.%20Jenkins&amp;volume=59&amp;publication_year=1996&amp;pages=1126-1133&amp;pmid=8900243&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77">
<cite>
Sunada S., Nakanishi A., Miki Y. (2018). Crosstalk of DNA Double‐strand Break Repair Pathways in poly(ADP‐ribose) Polymerase Inhibitor Treatment of Breast Cancer Susceptibility Gene 1/2‐mutated Cancer. Cancer Sci.
109, 893–899. 10.1111/cas.13530
</cite> [<a href="https://doi.org/10.1111/cas.13530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5891174/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29427345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci.&amp;title=Crosstalk%20of%20DNA%20Double%E2%80%90strand%20Break%20Repair%20Pathways%20in%20poly(ADP%E2%80%90ribose)%20Polymerase%20Inhibitor%20Treatment%20of%20Breast%20Cancer%20Susceptibility%20Gene%201/2%E2%80%90mutated%20Cancer&amp;author=S.%20Sunada&amp;author=A.%20Nakanishi&amp;author=Y.%20Miki&amp;volume=109&amp;publication_year=2018&amp;pages=893-899&amp;pmid=29427345&amp;doi=10.1111/cas.13530&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78">
<cite>
Tazzite A., Jouhadi H., Nadifi S., Aretini P., Falaschi E., Collavoli A., et al.  (2012). 
<em>BRCA1</em> and <em>BRCA2</em> Germline Mutations in Moroccan Breast/ovarian Cancer Families: Novel Mutations and Unclassified Variants. Gynecol. Oncol.
125, 687–692. 10.1016/j.ygyno.2012.03.007
</cite> [<a href="https://doi.org/10.1016/j.ygyno.2012.03.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22425665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol.%20Oncol.&amp;title=BRCA1%20and%20BRCA2%20Germline%20Mutations%20in%20Moroccan%20Breast/ovarian%20Cancer%20Families:%20Novel%20Mutations%20and%20Unclassified%20Variants&amp;author=A.%20Tazzite&amp;author=H.%20Jouhadi&amp;author=S.%20Nadifi&amp;author=P.%20Aretini&amp;author=E.%20Falaschi&amp;volume=125&amp;publication_year=2012&amp;pages=687-692&amp;pmid=22425665&amp;doi=10.1016/j.ygyno.2012.03.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79">
<cite>
The Council for Medical Schemes (2019). Final PMB Definition Guidelines for Ovarian Cancer. Pretoria, South Africa: Council for Medical Schemes, 1–27. Available at: <a href="https://www.medicalschemes.com/files/PMB/Project/FinalPMBdefinitionguidelineforovariancancer.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.medicalschemes.com/files/PMB/Project/FinalPMBdefinitionguidelineforovariancancer.pdf</a>
. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Final%20PMB%20Definition%20Guidelines%20for%20Ovarian%20Cancer&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80">
<cite>
Theme Filha M. M., Leal M. d. C., Oliveira E. F. V. d., Esteves-Pereira A. P., Gama S. G. N. d. (2016). Regional and Social Inequalities in the Performance of Pap Test and Screening Mammography and Their Correlation with Lifestyle: Brazilian National Health Survey, 2013. Int. J. Equity Health
15, 136. 10.1186/s12939-016-0430-9
</cite> [<a href="https://doi.org/10.1186/s12939-016-0430-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5112710/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27852313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Equity%20Health&amp;title=Regional%20and%20Social%20Inequalities%20in%20the%20Performance%20of%20Pap%20Test%20and%20Screening%20Mammography%20and%20Their%20Correlation%20with%20Lifestyle:%20Brazilian%20National%20Health%20Survey,%202013&amp;author=M.%20M.%20Theme%20Filha&amp;author=M.%20d.%20C.%20Leal&amp;author=E.%20F.%20V.%20d.%20Oliveira&amp;author=A.%20P.%20Esteves-Pereira&amp;author=S.%20G.%20N.%20d.%20Gama&amp;volume=15&amp;publication_year=2016&amp;pages=136&amp;pmid=27852313&amp;doi=10.1186/s12939-016-0430-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81">
<cite>
Troiano G., Nante N., Cozzolino M. (2017). The Angelina Jolie Effect - Impact on Breast and Ovarian Cancer Prevention A Systematic Review of Effects after the Public Announcement in May 2013. Health Edu. J.
76, 707–715. 10.1177/0017896917712300
</cite> [<a href="https://doi.org/10.1177/0017896917712300" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Health%20Edu.%20J.&amp;title=The%20Angelina%20Jolie%20Effect%20-%20Impact%20on%20Breast%20and%20Ovarian%20Cancer%20Prevention%20A%20Systematic%20Review%20of%20Effects%20after%20the%20Public%20Announcement%20in%20May%202013&amp;author=G.%20Troiano&amp;author=N.%20Nante&amp;author=M.%20Cozzolino&amp;volume=76&amp;publication_year=2017&amp;pages=707-715&amp;doi=10.1177/0017896917712300&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82">
<cite>
Troudi W., Loueslati B., Baccar A., Ben Ayed F., Ben Ammar El Gaaied A. (2009). Penetrance of BRCA1 Gene Mutation and DNA Mitochondrial in Tunisian Breast Cancer Occurrence. Tunis Med.
87, 494–498. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20180350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tunis%20Med.&amp;title=Penetrance%20of%20BRCA1%20Gene%20Mutation%20and%20DNA%20Mitochondrial%20in%20Tunisian%20Breast%20Cancer%20Occurrence&amp;author=W.%20Troudi&amp;author=B.%20Loueslati&amp;author=A.%20Baccar&amp;author=F.%20Ben%20Ayed&amp;author=A.%20Ben%20Ammar%20El%20Gaaied&amp;volume=87&amp;publication_year=2009&amp;pages=494-498&amp;pmid=20180350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83">
<cite>
Troudi W., Uhrhammer N., Sibille C., Dahan C., Mahfoudh W., Bouchlaka Souissi C., et al.  (2007). Contribution of the BRCA1 and BRCA2 Mutations to Breast Cancer in Tunisia. J. Hum. Genet.
52, 915–920. 10.1007/s10038-007-0195-5
</cite> [<a href="https://doi.org/10.1007/s10038-007-0195-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17922257/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Contribution%20of%20the%20BRCA1%20and%20BRCA2%20Mutations%20to%20Breast%20Cancer%20in%20Tunisia&amp;author=W.%20Troudi&amp;author=N.%20Uhrhammer&amp;author=C.%20Sibille&amp;author=C.%20Dahan&amp;author=W.%20Mahfoudh&amp;volume=52&amp;publication_year=2007&amp;pages=915-920&amp;pmid=17922257&amp;doi=10.1007/s10038-007-0195-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84">
<cite>
Van der Merwe N. C., van Rensburg E. J. (2009). Hereditary Breast/ovarian Cancer and BRCA Mutations: A South African Perspective. Curr. Oncol.
16, 91. </cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Oncol.&amp;title=Hereditary%20Breast/ovarian%20Cancer%20and%20BRCA%20Mutations:%20A%20South%20African%20Perspective&amp;author=N.%20C.%20Van%20der%20Merwe&amp;author=E.%20J.%20van%20Rensburg&amp;volume=16&amp;publication_year=2009&amp;pages=91&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85">
<cite>
Van der Merwe N. C., Oosthuizen J., Theron M., Chong G., Foulkes W. D. (2020). The Contribution of Large Genomic Rearrangements in <em>BRCA1</em> and <em>BRCA2</em> to South African Familial Breast Cancer. BMC Cancer
20, 391. 10.1186/s12885-020-06917-y
</cite> [<a href="https://doi.org/10.1186/s12885-020-06917-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7203887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32375709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=The%20Contribution%20of%20Large%20Genomic%20Rearrangements%20in%20BRCA1%20and%20BRCA2%20to%20South%20African%20Familial%20Breast%20Cancer&amp;author=N.%20C.%20Van%20der%20Merwe&amp;author=J.%20Oosthuizen&amp;author=M.%20Theron&amp;author=G.%20Chong&amp;author=W.%20D.%20Foulkes&amp;volume=20&amp;publication_year=2020&amp;pages=391&amp;pmid=32375709&amp;doi=10.1186/s12885-020-06917-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86">
<cite>
Van der Merwe N., Hamel N., Schneider S.-R., Apffelstaedt J., Wijnen J., Foulkes W. (2012). A Founder <em>BRCA2</em> Mutation in Non-afrikaner Breast Cancer Patients of the Western Cape of South Africa. Clin. Genet.
81, 179–184. 10.1111/j.1399-0004.2010.01617.x
</cite> [<a href="https://doi.org/10.1111/j.1399-0004.2010.01617.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21204799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=A%20Founder%20BRCA2%20Mutation%20in%20Non-afrikaner%20Breast%20Cancer%20Patients%20of%20the%20Western%20Cape%20of%20South%20Africa&amp;author=N.%20Van%20der%20Merwe&amp;author=N.%20Hamel&amp;author=S.-R.%20Schneider&amp;author=J.%20Apffelstaedt&amp;author=J.%20Wijnen&amp;volume=81&amp;publication_year=2012&amp;pages=179-184&amp;pmid=21204799&amp;doi=10.1111/j.1399-0004.2010.01617.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87">
<cite>
Vishnu P., Morrell R. (1991). Indian Merchants and Dukawallahs in the Natal Economy, C1875-1914. J. South. Afr. Stud.
17, 71–102. <a href="https://www.jstor.org/stable/2637287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.jstor.org/stable/2637287</a>. </cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20South.%20Afr.%20Stud.&amp;title=Indian%20Merchants%20and%20Dukawallahs%20in%20the%20Natal%20Economy,%20C1875-1914&amp;author=P.%20Vishnu&amp;author=R.%20Morrell&amp;volume=17&amp;publication_year=1991&amp;pages=71-102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B88">
<cite>
World Health Organization Africa
The State of Health in the WHO African Region: An Analysis of the Status of Health. Available at: <a href="https://reliefweb.int/report/world/state-heatlh-who-african-region-analysis-status-health-services-and-health" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://reliefweb.int/report/world/state-heatlh-who-african-region-analysis-status-health-services-and-health</a> (Accessed November 14, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=The%20State%20of%20Health%20in%20the%20WHO%20African%20Region:%20An%20Analysis%20of%20the%20Status%20of%20Health&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B89">
<cite>
Yawitch T. M. (2005). Inherited Predisposition to Breast/ovarian Cancer: The Frequency and Nature of <em>BRCA1</em> Gene Mutations in South African familiesMScMed Dissertation. Pretoria: University of Pretoria. Available at: <a href="https://repository.up.ac.za/handle/2263/30470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://repository.up.ac.za/handle/2263/30470</a> (Accessed September 14, 2021). </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Inherited%20Predisposition%20to%20Breast/ovarian%20Cancer:%20The%20Frequency%20and%20Nature%20of%20BRCA1%20Gene%20Mutations%20in%20South%20African%20familiesMScMed%20Dissertation&amp;author=T.%20M.%20Yawitch&amp;publication_year=2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B90">
<cite>
Yoshida K., Miki Y. (2004). Role of <em>BRCA1</em> and <em>BRCA2</em> as Regulators of DNA Repair, Transcription, and Cell Cycle in Response to DNA Damage. Cancer Sci.
95, 866–871. 10.1111/j.1349-7006.2004.tb0219510.1111/j.1349-7006.2004.tb02195.x
</cite> [<a href="https://doi.org/10.1111/j.1349-7006.2004.tb0219510.1111/j.1349-7006.2004.tb02195.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11159131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15546503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci.&amp;title=Role%20of%20BRCA1%20and%20BRCA2%20as%20Regulators%20of%20DNA%20Repair,%20Transcription,%20and%20Cell%20Cycle%20in%20Response%20to%20DNA%20Damage&amp;author=K.%20Yoshida&amp;author=Y.%20Miki&amp;volume=95&amp;publication_year=2004&amp;pages=866-871&amp;pmid=15546503&amp;doi=10.1111/j.1349-7006.2004.tb0219510.1111/j.1349-7006.2004.tb02195.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B91">
<cite>
Zhang B., Fackenthal J. D., Niu Q., Huo D., Sveen W. E., AdebamowoDeMarco C. A., et al.  (2009). Evidence for an Ancient <em>BRCA1</em> Mutation in Breast Cancer Patients of Yoruban Ancestry. Fam. Cancer
8, 15–22. 10.1007/s10689-008-9205-9
</cite> [<a href="https://doi.org/10.1007/s10689-008-9205-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18679828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam.%20Cancer&amp;title=Evidence%20for%20an%20Ancient%20BRCA1%20Mutation%20in%20Breast%20Cancer%20Patients%20of%20Yoruban%20Ancestry&amp;author=B.%20Zhang&amp;author=J.%20D.%20Fackenthal&amp;author=Q.%20Niu&amp;author=D.%20Huo&amp;author=W.%20E.%20Sveen&amp;volume=8&amp;publication_year=2009&amp;pages=15-22&amp;pmid=18679828&amp;doi=10.1007/s10689-008-9205-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B92">
<cite>
Zhang J., Fackenthal J. D., Zheng Y., Huo D., Hou N., Niu Q., et al.  (2012). Recurrent <em>BRCA1</em> and <em>BRCA2</em> Mutations in Breast Cancer Patients of African Ancestry. Breast Cancer Res. Treat.
134, 889–894. 10.1007/s10549-012-2136-z
</cite> [<a href="https://doi.org/10.1007/s10549-012-2136-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22739995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Recurrent%20BRCA1%20and%20BRCA2%20Mutations%20in%20Breast%20Cancer%20Patients%20of%20African%20Ancestry&amp;author=J.%20Zhang&amp;author=J.%20D.%20Fackenthal&amp;author=Y.%20Zheng&amp;author=D.%20Huo&amp;author=N.%20Hou&amp;volume=134&amp;publication_year=2012&amp;pages=889-894&amp;pmid=22739995&amp;doi=10.1007/s10549-012-2136-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B93">
<cite>
Zheng Y., Walsh T., Gulsuner S., Casadei S., Lee M. K., Ogundiran T. O., et al.  (2018). Inherited Breast Cancer in Nigerian Women. Jco
36, 2820–2825. 10.1200/JCO.2018.78.3977
</cite> [<a href="https://doi.org/10.1200/JCO.2018.78.3977" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6161833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30130155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Jco&amp;title=Inherited%20Breast%20Cancer%20in%20Nigerian%20Women&amp;author=Y.%20Zheng&amp;author=T.%20Walsh&amp;author=S.%20Gulsuner&amp;author=S.%20Casadei&amp;author=M.%20K.%20Lee&amp;volume=36&amp;publication_year=2018&amp;pages=2820-2825&amp;pmid=30130155&amp;doi=10.1200/JCO.2018.78.3977&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.1KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table2.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table3.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (13KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9024354/bin/Table4.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (23.7KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#s12" class="usa-link">Supplementary Material</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Genetics are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fgene.2022.834265"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fgene-13-834265.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9024354/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9024354/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9024354%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9024354/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9024354/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9024354/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35464868/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9024354/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35464868/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9024354/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9024354/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="tDrvQUi7mgr6Z08zpoJz9p9pWGAznUta5NRICMLFDYVqa6DAFn79Gx253yZMqFYF">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
